Amedeo Smart

Free Medical Literature Service


 

Amedeo

Influenza

  Free Subscription

Articles published in
N Engl J Med
    June 2024
  1. KAISER F, Morris DH, Wickenhagen A, Mukesh R, et al
    Inactivation of Avian Influenza A(H5N1) Virus in Raw Milk at 63 degrees C and 72 degrees C.
    N Engl J Med. 2024 Jun 14. doi: 10.1056/NEJMc2405488.
    >> Share

  2. OWUSU-ANSAH S, Green Rodgers P
    Reviving Hearts - Uniting Communities with Lifesaving Bystander CPR.
    N Engl J Med. 2024;390:2040-2041.
    >> Share

  3. HAMPSHIRE A, Elliott P
    Cognition and Memory after Covid-19 in a Large Community Sample. Reply.
    N Engl J Med. 2024;390:2035.
    >> Share

  4. XU L, Huang X, Li Y
    Cognition and Memory after Covid-19 in a Large Community Sample.
    N Engl J Med. 2024;390:2034-2035.
    >> Share

  5. BUONSENSO D
    Cognition and Memory after Covid-19 in a Large Community Sample.
    N Engl J Med. 2024;390:2034.
    >> Share

    May 2024
  6. HALABI S, Gostin LO, Egbokhare O, Kavanagh MM, et al
    Global Health Law for a Safer and Fairer World.
    N Engl J Med. 2024;390:1925-1931.
    >> Share

  7. LIN DY, Du Y, Xu Y, Paritala S, et al
    Durability of XBB.1.5 Vaccines against Omicron Subvariants.
    N Engl J Med. 2024 May 29. doi: 10.1056/NEJMc2402779.
    >> Share

  8. GUAN L, Eisfeld AJ, Pattinson D, Gu C, et al
    Cow's Milk Containing Avian Influenza A(H5N1) Virus - Heat Inactivation and Infectivity in Mice.
    N Engl J Med. 2024 May 24. doi: 10.1056/NEJMc2405495.
    >> Share

  9. RUBIN EJ, Baden LR, Daskalakis D, Marston H, et al
    Audio Interview: Preparing for a Possible Avian Influenza Outbreak.
    N Engl J Med. 2024 May 22. doi: 10.1056/NEJMe2406224.
    >> Share

  10. RUBIN EJ, Baden LR, Marrazzo J, Monto A, et al
    Audio Interview: The Current State of Avian Influenza.
    N Engl J Med. 2024 May 20. doi: 10.1056/NEJMe2406223.
    >> Share

  11. HERBERT C, McManus DD, Soni A
    False Positive Covid-19 Rapid Antigen Tests. Reply.
    N Engl J Med. 2024;390:1836.
    >> Share

  12. YANG C, Espin E, Tebbutt SJ
    False Positive Covid-19 Rapid Antigen Tests.
    N Engl J Med. 2024;390:1835-1836.
    >> Share

  13. SCHUBACH A, Ricotta D, Kittleson MM
    To Preround or Not to Preround.
    N Engl J Med. 2024;390:1824-1826.
    >> Share

  14. UYEKI TM, Milton S, Abdul Hamid C, Reinoso Webb C, et al
    Highly Pathogenic Avian Influenza A(H5N1) Virus Infection in a Dairy Farm Worker.
    N Engl J Med. 2024 May 3. doi: 10.1056/NEJMc2405371.
    >> Share

    April 2024
  15. WANG Y, Hu H, Cao B
    Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19. Reply.
    N Engl J Med. 2024;390:1534-1535.
    >> Share

  16. SELVI-SABATER P, de la Rubia Orti JE, Urbieta-Sanz E
    Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19.
    N Engl J Med. 2024;390:1534.
    >> Share

  17. MOSER CB, Li JZ, Hughes MD
    Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19.
    N Engl J Med. 2024;390:1533-1534.
    >> Share

  18. GANDHI RT, Hirsch M
    Treating Acute Covid-19 - Final Chapters Still Unwritten.
    N Engl J Med. 2024;390:1234-1236.
    >> Share

  19. HAMMOND J, Fountaine RJ, Yunis C, Fleishaker D, et al
    Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19.
    N Engl J Med. 2024;390:1186-1195.
    >> Share

    March 2024
  20. HSIAO A, Fireman B, Klein NP
    Recombinant Influenza Vaccine in Adults under 65 Years of Age. Reply.
    N Engl J Med. 2024;390:1156.
    >> Share

  21. WOO EJ, Hulse AN
    Recombinant Influenza Vaccine in Adults under 65 Years of Age.
    N Engl J Med. 2024;390:1155-1156.
    >> Share

  22. HAVIARI S, Massonnaud CR, Dupont A
    Recombinant Influenza Vaccine in Adults under 65 Years of Age.
    N Engl J Med. 2024;390:1155.
    >> Share

  23. DIEUSSAERT I, Hyung Kim J, Luik S, Seidl C, et al
    RSV Prefusion F Protein-Based Maternal Vaccine - Preterm Birth and Other Outcomes.
    N Engl J Med. 2024;390:1009-1021.
    >> Share

    February 2024
  24. ELLINGJORD-DALE M, Brunvoll SH, Soraas A
    Prospective Memory Assessment before and after Covid-19.
    N Engl J Med. 2024;390:863-865.
    >> Share

  25. AL-ALY Z, Rosen CJ
    Long Covid and Impaired Cognition - More Evidence and More Work to Do.
    N Engl J Med. 2024;390:858-860.
    >> Share

  26. HAMPSHIRE A, Azor A, Atchison C, Trender W, et al
    Cognition and Memory after Covid-19 in a Large Community Sample.
    N Engl J Med. 2024;390:806-818.
    >> Share

  27. MONTO AS, Zambon M, Weir JP
    The End of B/Yamagata Influenza Transmission - Transitioning from Quadrivalent Vaccines.
    N Engl J Med. 2024 Feb 28. doi: 10.1056/NEJMp2314801.
    >> Share

  28. BENEZECH S, Khoryati L, Belot A
    More on Pre-Covid-19, SARS-CoV-2-Negative MIS-C. Reply.
    N Engl J Med. 2024;390:771-772.
    >> Share

  29. FRANCO A, Tremoulet A, Burns JC
    More on Pre-Covid-19, SARS-CoV-2-Negative MIS-C.
    N Engl J Med. 2024;390:771.
    >> Share

  30. HERBERT C, McManus DD, Soni A
    Persistent False Positive Covid-19 Rapid Antigen Tests.
    N Engl J Med. 2024;390:764-765.
    >> Share

    January 2024
  31. MISSET B, Desmecht D, Laterre PF
    Convalescent Plasma for Covid-19-Induced ARDS. Reply.
    N Engl J Med. 2024;390:386.
    >> Share

  32. CASADEVALL A, Shoham S, Pirofski LA
    Convalescent Plasma for Covid-19-Induced ARDS.
    N Engl J Med. 2024;390:385-386.
    >> Share

  33. SENEFELD JW, Henderson JP, Joyner MJ
    Convalescent Plasma for Covid-19-Induced ARDS.
    N Engl J Med. 2024;390:385.
    >> Share

  34. BORGHESI A, Casanova JL
    Convalescent Plasma for Covid-19-Induced ARDS.
    N Engl J Med. 2024;390:384-385.
    >> Share

  35. CAO B, Wang Y, Lu H, Huang C, et al
    Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19.
    N Engl J Med. 2024;390:230-241.
    >> Share

    December 2023
  36. HALASA NB
    RSV Prevention - Breakthroughs and Challenges.
    N Engl J Med. 2023;389:2480-2481.
    >> Share

  37. DRYSDALE SB, Cathie K, Flamein F, Knuf M, et al
    Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants.
    N Engl J Med. 2023;389:2425-2435.
    >> Share


  38. Covid Update: ITT Episode 23.
    N Engl J Med. 2023;389:e52.
    >> Share

  39. HSIAO A, Yee A, Fireman B, Hansen J, et al
    Recombinant or Standard-Dose Influenza Vaccine in Adults under 65 Years of Age.
    N Engl J Med. 2023;389:2245-2255.
    >> Share

  40. COHN AC, Hall AJ
    Continued Progress in the Development of Safe and Effective RSV Immunizations.
    N Engl J Med. 2023;389:2289-2290.
    >> Share

  41. WILSON E, Goswami J, Baqui AH, Doreski PA, et al
    Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults.
    N Engl J Med. 2023;389:2233-2244.
    >> Share

    November 2023
  42. BENEZECH S, Khoryati L, Cognard J, Netea SA, et al
    Pre-Covid-19, SARS-CoV-2-Negative Multisystem Inflammatory Syndrome in Children.
    N Engl J Med. 2023;389:2105-2107.
    >> Share

  43. WANG Y, Guo Z, Ye B, Liu L, et al
    Association of SARS-CoV-2 Infection during Early Weeks of Gestation with Situs Inversus.
    N Engl J Med. 2023;389:1722-1724.
    >> Share

    October 2023
  44. MISSET B, Piagnerelli M, Hoste E, Dardenne N, et al
    Convalescent Plasma for Covid-19-Induced ARDS in Mechanically Ventilated Patients.
    N Engl J Med. 2023;389:1590-1600.
    >> Share

  45. BLADH O, Greilert-Norin N, Havervall S, Marking U, et al
    Mucosal and Serum Antibodies 3 Weeks after Symptomatic BA.2.86 Infection.
    N Engl J Med. 2023;389:1626-1628.
    >> Share

  46. HILLS TE, Lorenzi E, Berry LR, Shyamsundar M, et al
    Simvastatin in Critically Ill Patients with Covid-19.
    N Engl J Med. 2023 Oct 25. doi: 10.1056/NEJMoa2309995.
    >> Share


  47. The Long Haul of Long Covid.
    N Engl J Med. 2023;389:e29.
    >> Share

  48. ABI-RACHED JM, Brandt AM
    Do Pandemics Ever End?
    N Engl J Med. 2023;389:1349-1351.
    >> Share

    September 2023
  49. BOULWARE DR, Lindsell CJ, Stewart TG, Hernandez AF, et al
    Inhaled Fluticasone Furoate for Outpatient Treatment of Covid-19.
    N Engl J Med. 2023;389:1085-1095.
    >> Share

    August 2023
  50. MURRAY EJ, Cowger TL, Hall KT
    Lifting Universal School Masking - Covid-19 Incidence among Students and Staff. Reply.
    N Engl J Med. 2023;389:580.
    >> Share

  51. MARINE JE
    Lifting Universal School Masking - Covid-19 Incidence among Students and Staff.
    N Engl J Med. 2023;389:579.
    >> Share

  52. LADHANI SN, Andrews N, Ramsay ME
    Lifting Universal School Masking - Covid-19 Incidence among Students and Staff.
    N Engl J Med. 2023;389:579.
    >> Share

  53. RUSSELL FM, Curtis N, Carlin J
    Lifting Universal School Masking - Covid-19 Incidence among Students and Staff.
    N Engl J Med. 2023;389:578-579.
    >> Share

  54. KRISCHER JP, Lernmark A, Hagopian WA, Rewers MJ, et al
    SARS-CoV-2 - No Increased Islet Autoimmunity or Type 1 Diabetes in Teens.
    N Engl J Med. 2023;389:474-475.
    >> Share

    July 2023
  55. BECERRA X, Jha A
    Project NextGen - Defeating SARS-CoV-2 and Preparing for the Next Pandemic.
    N Engl J Med. 2023 Jul 26. doi: 10.1056/NEJMp2307867.
    >> Share

  56. ARBEL R, Sergienko R, Netzer D, Hammerman A, et al
    Potential "Healthy Vaccinee Bias" in a Study of BNT162b2 Vaccine against Covid-19. Reply.
    N Engl J Med. 2023;389:285-286.
    >> Share

  57. HOEG TB, Duriseti R, Prasad V
    Potential "Healthy Vaccinee Bias" in a Study of BNT162b2 Vaccine against Covid-19.
    N Engl J Med. 2023;389:284-285.
    >> Share

  58. MCCRINDLE BW, Manlhiot C
    More on SARS-CoV-2 Variants and Pediatric Multisystem Inflammatory Syndrome. Reply.
    N Engl J Med. 2023;389:287-288.
    >> Share

  59. XIA CY, Niu MM, Hu P
    More on SARS-CoV-2 Variants and Pediatric Multisystem Inflammatory Syndrome.
    N Engl J Med. 2023;389:287.
    >> Share

  60. PITTET LF, Messina NL, Curtis N
    BCG to Protect against Covid-19 in Health Care Workers. Reply.
    N Engl J Med. 2023;389:192.
    >> Share

  61. BENN CS, Netea MG, Aaby P
    BCG to Protect against Covid-19 in Health Care Workers.
    N Engl J Med. 2023;389:191-192.
    >> Share

  62. LOPEZ-CAMPOS GH, Valvano MA
    BCG to Protect against Covid-19 in Health Care Workers.
    N Engl J Med. 2023;389:191.
    >> Share

    June 2023
  63. HALABI S, Wilder R, Gostin LO, Hurtado ML, et al
    Sharing Pathogen Genomic Sequence Data - Toward Effective Pandemic Prevention, Preparedness, and Response.
    N Engl J Med. 2023;388:2401-2404.
    >> Share

  64. CAO Z, Gao Y, Zhao R
    VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19. Reply.
    N Engl J Med. 2023;388:2396-2397.
    >> Share

  65. LI Y
    VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19.
    N Engl J Med. 2023;388:2396.
    >> Share

  66. EDWARDS JL
    VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19.
    N Engl J Med. 2023;388:2395-2396.
    >> Share

  67. BERGMANN F, Jorda A, Zeitlinger M
    VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19.
    N Engl J Med. 2023;388:2395.
    >> Share

  68. LIN DY, Fleming TR
    VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19.
    N Engl J Med. 2023;388:2395.
    >> Share

  69. MCGARRY BE, Gandhi AD, Barnett ML
    Covid-19 Surveillance Testing in Nursing Homes. Reply.
    N Engl J Med. 2023;388:2207-2208.
    >> Share

  70. STALL NM, Kain DC, Johnstone J
    Covid-19 Surveillance Testing in Nursing Homes.
    N Engl J Med. 2023;388:2207.
    >> Share

  71. DORFMAN D, Berger Z
    Approving Workplace Accommodations for Patients with Long Covid - Advice for Clinicians.
    N Engl J Med. 2023;388:2115-2117.
    >> Share

  72. NIKOLICH JZ, Rosen CJ
    Toward Comprehensive Care for Long Covid.
    N Engl J Med. 2023;388:2113-2115.
    >> Share

  73. GOSTIN LO, Gronvall GK
    The Origins of Covid-19 - Why It Matters (and Why It Doesn't).
    N Engl J Med. 2023 Jun 7. doi: 10.1056/NEJMp2305081.
    >> Share

  74. TSUBOI M, Herbst RS, John T, Kato T, et al
    Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.
    N Engl J Med. 2023 Jun 4. doi: 10.1056/NEJMoa2304594.
    >> Share

  75. REIS G, Mills EJ, Glenn JS
    Pegylated Interferon Lambda for Covid-19. Reply.
    N Engl J Med. 2023;388:2108.
    >> Share

  76. WANG M, Tang L, Huang L
    Pegylated Interferon Lambda for Covid-19.
    N Engl J Med. 2023;388:2107-2108.
    >> Share

  77. ANDREAKOS E, Tsiodras S
    Pegylated Interferon Lambda for Covid-19.
    N Engl J Med. 2023;388:2107.
    >> Share

    May 2023
  78. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: The Lasting Effects of Covid-19.
    N Engl J Med. 2023;388:e76.
    >> Share

  79. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Ending the Covid-19 Emergency.
    N Engl J Med. 2023;388:e72.
    >> Share

  80. LISCO A, Ortega-Villa AM, Mystakelis H, Anderson MV, et al
    Reappraisal of Idiopathic CD4 Lymphocytopenia at 30 Years.
    N Engl J Med. 2023;388:1680-1691.
    >> Share

    April 2023
  81. PITTET LF, Messina NL, Orsini F, Moore CL, et al
    Randomized Trial of BCG Vaccine to Protect against Covid-19 in Health Care Workers.
    N Engl J Med. 2023;388:1582-1596.
    >> Share

  82. KARRON RA
    RSV Illness in the Young and the Old - The Beginning of the End?
    N Engl J Med. 2023;388:1522-1524.
    >> Share

  83. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: When to Get a Second Covid-19 Booster Shot.
    N Engl J Med. 2023;388:e64.
    >> Share

  84. ADAMS G, Moreno GK, Petros BA, Uddin R, et al
    Viral Lineages in the 2022 RSV Surge in the United States.
    N Engl J Med. 2023;388:1335-1337.
    >> Share

  85. KAMPMANN B, Madhi SA, Munjal I, Simoes EAF, et al
    Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants.
    N Engl J Med. 2023 Apr 5. doi: 10.1056/NEJMoa2216480.
    >> Share

  86. MULLER WJ, Madhi SA, Seoane Nunez B, Baca Cots M, et al
    Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants.
    N Engl J Med. 2023 Apr 5. doi: 10.1056/NEJMc2214773.
    >> Share

  87. WALSH EE, Perez Marc G, Zareba AM, Falsey AR, et al
    Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults.
    N Engl J Med. 2023 Apr 5. doi: 10.1056/NEJMoa2213836.
    >> Share

    March 2023
  88. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Ending the Covid-19 Public Health Emergency.
    N Engl J Med. 2023;388:e53.
    >> Share

  89. JABAGI MJ, Bertrand M, Botton J, Le Vu S, et al
    Stroke, Myocardial Infarction, and Pulmonary Embolism after Bivalent Booster.
    N Engl J Med. 2023 Mar 29. doi: 10.1056/NEJMc2302134.
    >> Share

  90. NEUZIL KM
    An mRNA Influenza Vaccine - Could It Deliver?
    N Engl J Med. 2023;388:1139-1141.
    >> Share

  91. MCGARRY BE, Gandhi AD, Barnett ML
    Covid-19 Surveillance Testing and Resident Outcomes in Nursing Homes.
    N Engl J Med. 2023;388:1101-1110.
    >> Share

  92. MCCRINDLE BW, Harahsheh AS, Handoko R, Raghuveer G, et al
    SARS-CoV-2 Variants and Multisystem Inflammatory Syndrome in Children.
    N Engl J Med. 2023 Mar 22. doi: 10.1056/NEJMc2215074.
    >> Share

  93. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: The Future of Covid-19 Research.
    N Engl J Med. 2023;388:e39.
    >> Share

  94. MANSOUR MK, King JD, Chen ST, Fishman JA, et al
    Case 7-2023: A 70-Year-Old Man with Covid-19, Respiratory Failure, and Rashes.
    N Engl J Med. 2023;388:926-937.
    >> Share

  95. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: The Path Forward for Covid-19 Therapeutics.
    N Engl J Med. 2023;388:e36.
    >> Share

  96. OFFIT PA
    Bivalent Covid-19 Vaccines. Reply.
    N Engl J Med. 2023;388:10.
    >> Share

  97. MARKS PW, Califf RM
    Bivalent Covid-19 Vaccines.
    N Engl J Med. 2023;388:10.
    >> Share

  98. LI D, Duan M, Wang X, Gao P, et al
    Neutralization of BQ.1, BQ.1.1, and XBB with RBD-Dimer Vaccines.
    N Engl J Med. 2023 Mar 1. doi: 10.1056/NEJMc2216233.
    >> Share

    February 2023
  99. RUBIN EJ, Baden LR, Graham BS, Morrissey S, et al
    Audio Interview: What to Expect from Covid-19 Vaccines.
    N Engl J Med. 2023;388:e23.
    >> Share

  100. MUNOZ FM, Sher LD, Sabharwal C, Gurtman A, et al
    Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of Age.
    N Engl J Med. 2023;388:621-634.
    >> Share

  101. FALSEY AR, Williams K, Gymnopoulou E, Bart S, et al
    Efficacy and Safety of an Ad26.RSV.preF-RSV preF Protein Vaccine in Older Adults.
    N Engl J Med. 2023;388:609-620.
    >> Share

  102. PAPI A, Ison MG, Langley JM, Lee DG, et al
    Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults.
    N Engl J Med. 2023;388:595-608.
    >> Share

  103. GRAHAM BS
    The Journey to RSV Vaccines - Heralding an Era of Structure-Based Design.
    N Engl J Med. 2023;388:579-581.
    >> Share

  104. CHEMAITELLY H, Tang P, Coyle P, Yassine HM, et al
    Protection against Reinfection with the Omicron BA.2.75 Subvariant.
    N Engl J Med. 2023;388:665-667.
    >> Share

  105. HUTH L, Schafer L, Almanzar G, Lupoli G, et al
    Immunologic Effect of Bivalent mRNA Booster in Patients Undergoing Hemodialysis.
    N Engl J Med. 2023 Feb 15. doi: 10.1056/NEJMc2216309.
    >> Share

  106. REIS G, Moreira Silva EAS, Medeiros Silva DC, Thabane L, et al
    Early Treatment with Pegylated Interferon Lambda for Covid-19.
    N Engl J Med. 2023;388:518-528.
    >> Share

  107. WANG Q, Bowen A, Valdez R, Gherasim C, et al
    Antibody Response to Omicron BA.4-BA.5 Bivalent Booster.
    N Engl J Med. 2023;388:567-569.
    >> Share

  108. EL-SADR WM, Vasan A, El-Mohandes A
    Facing the New Covid-19 Reality.
    N Engl J Med. 2023;388:385-387.
    >> Share

  109. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Updating and Standardizing Covid-19 Vaccines.
    N Engl J Med. 2023;388:e21.
    >> Share

    January 2023

  110. Covid Vaccines - Playing the Long Game.
    N Engl J Med. 2023;388:e5.
    >> Share

  111. ZOU J, Kurhade C, Patel S, Kitchin N, et al
    Neutralization of BA.4-BA.5, BA.4.6, BA.2.75.2, BQ.1.1, and XBB.1 with Bivalent Vaccine.
    N Engl J Med. 2023 Jan 25. doi: 10.1056/NEJMc2214916.
    >> Share

  112. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Weighing the Protective Value of Covid-19 Infection.
    N Engl J Med. 2023;388:e13.
    >> Share

  113. WINOKUR P, Gayed J, Fitz-Patrick D, Thomas SJ, et al
    Bivalent Omicron BA.1-Adapted BNT162b2 Booster in Adults Older than 55 Years.
    N Engl J Med. 2023;388:214-227.
    >> Share

  114. MILLER J, Hachmann NP, Collier AY, Lasrado N, et al
    Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1.
    N Engl J Med. 2023 Jan 18. doi: 10.1056/NEJMc2214314.
    >> Share

  115. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Covid-19 Vaccines and New Viral Variants.
    N Engl J Med. 2023;388:e8.
    >> Share

  116. SCHUSTER JE, Hamdan L, Dulek DE, Kitko CL, et al
    Influenza Vaccine in Pediatric Recipients of Hematopoietic-Cell Transplants.
    N Engl J Med. 2023 Jan 11. doi: 10.1056/NEJMc2210825.
    >> Share

  117. OFFIT PA
    Bivalent Covid-19 Vaccines - A Cautionary Tale.
    N Engl J Med. 2023 Jan 11. doi: 10.1056/NEJMp2215780.
    >> Share

  118. COLLIER AY, Miller J, Hachmann NP, McMahan K, et al
    Immunogenicity of BA.5 Bivalent mRNA Vaccine Boosters.
    N Engl J Med. 2023 Jan 11. doi: 10.1056/NEJMc2213948.
    >> Share

  119. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: The Expanding Arsenal of Oral Agents to Treat Covid-19.
    N Engl J Med. 2023;388:e7.
    >> Share

  120. IMAI M, Ito M, Kiso M, Yamayoshi S, et al
    Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB.
    N Engl J Med. 2023;388:89-91.
    >> Share

    December 2022
  121. ARBEL R, Wolff Sagy Y, Hammerman A
    Nirmatrelvir Use during the Omicron Surge. Reply.
    N Engl J Med. 2022;387:2480-2481.
    >> Share

  122. WEISS G
    Nirmatrelvir Use during the Omicron Surge.
    N Engl J Med. 2022;387:2480.
    >> Share

  123. NIELD B
    Nirmatrelvir Use during the Omicron Surge.
    N Engl J Med. 2022;387:2479-2480.
    >> Share

  124. SWETS MC, de Boer MGJ, Groeneveld GH
    Nirmatrelvir Use during the Omicron Surge.
    N Engl J Med. 2022;387:2479.
    >> Share

  125. CAO Z, Gao W, Bao H, Feng H, et al
    VV116 versus Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19.
    N Engl J Med. 2022 Dec 28. doi: 10.1056/NEJMoa2208822.
    >> Share

  126. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Potential Covid Vaccine Strategies.
    N Engl J Med. 2022;387:e75.
    >> Share

  127. REIS G, Mills EJ
    Ivermectin Treatment for Covid-19. Reply.
    N Engl J Med. 2022;387:e66.
    >> Share

  128. BARUS R, Gautier S, Wabont G
    Ivermectin Treatment for Covid-19.
    N Engl J Med. 2022;387:e66.
    >> Share

  129. MEJIA JH, Jimenez CA
    Ivermectin Treatment for Covid-19.
    N Engl J Med. 2022;387:e66.
    >> Share

  130. FURLAN L
    Ivermectin Treatment for Covid-19.
    N Engl J Med. 2022;387:e66.
    >> Share

  131. BRAMANTE CT, Buse JB, Boulware DR
    Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19. Reply.
    N Engl J Med. 2022;387:e65.
    >> Share

  132. SHUKLA AK, Misra S
    Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19.
    N Engl J Med. 2022;387:e65.
    >> Share

  133. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Applying New Studies of Mpox and Ebola to Covid-19.
    N Engl J Med. 2022;387:e74.
    >> Share

  134. GILBERT PB, Donis RO, Koup RA, Fong Y, et al
    A Covid-19 Milestone Attained - A Correlate of Protection for Vaccines.
    N Engl J Med. 2022;387:2203-2206.
    >> Share

  135. RUBIN EJ, Baden LR, Hlatshwayo Davis M, Morrissey S, et al
    Audio Interview: Covid-19 and Health Equity.
    N Engl J Med. 2022;387:e73.
    >> Share

  136. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Five Disease Outbreaks beyond Covid-19.
    N Engl J Med. 2022;387:e68.
    >> Share

  137. TAKASHITA E, Yamayoshi S, Halfmann P, Wilson N, et al
    In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6.
    N Engl J Med. 2022;387:2094-2097.
    >> Share

    November 2022
  138. ABERG M, Smed-Sorensen A, Thalin C
    Mucosal IgA against SARS-CoV-2 Omicron Infection. Reply.
    N Engl J Med. 2022;387:e55.
    >> Share

  139. ZUO F, Marcotte H, Hammarstrom L, Pan-Hammarstrom Q, et al
    Mucosal IgA against SARS-CoV-2 Omicron Infection.
    N Engl J Med. 2022;387:e55.
    >> Share

  140. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Making Choices about Covid-19.
    N Engl J Med. 2022;387:e64.
    >> Share

  141. RUBIN EJ, Baden LR, Marks P, Morrissey S, et al
    Audio Interview: The FDA and Covid-19 Vaccines.
    N Engl J Med. 2022;387:e60.
    >> Share

  142. GOLDEN MR, Wasserheit JN
    Monkeypox - A Sobering Sentinel for Pandemic Preparedness and Sexual Health System Capacity.
    N Engl J Med. 2022;387:1826-1829.
    >> Share

  143. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Masking and Covid-19.
    N Engl J Med. 2022;387:e56.
    >> Share

  144. VENKATARAMANI V, Winkler F
    Cognitive Deficits in Long Covid-19.
    N Engl J Med. 2022;387:1813-1815.
    >> Share

  145. FRICCHIONE GL, Paul AB, Chemali Z, Kritzer MD, et al
    Case 34-2022: A 57-Year-Old Woman with Covid-19 and Delusions.
    N Engl J Med. 2022;387:1795-1803.
    >> Share

  146. RAIFMAN J, Green T
    Universal Masking Policies in Schools and Mitigating the Inequitable Costs of Covid-19.
    N Engl J Med. 2022 Nov 9. doi: 10.1056/NEJMe2213556.
    >> Share

  147. COWGER TL, Murray EJ, Clarke J, Bassett MT, et al
    Lifting Universal Masking in Schools - Covid-19 Incidence among Students and Staff.
    N Engl J Med. 2022 Nov 9. doi: 10.1056/NEJMoa2211029.
    >> Share

  148. CANETTI M, Barda N, Gilboa M, Indenbaum V, et al
    Six-Month Follow-up after a Fourth BNT162b2 Vaccine Dose.
    N Engl J Med. 2022 Nov 9. doi: 10.1056/NEJMc2211283.
    >> Share

  149. CHESKES S, Verbeek PR, Drennan IR, McLeod SL, et al
    Defibrillation Strategies for Refractory Ventricular Fibrillation.
    N Engl J Med. 2022 Nov 6. doi: 10.1056/NEJMoa2207304.
    >> Share

  150. RUBIN EJ, Baden LR, Hardin CC, Morrissey S, et al
    Audio Interview: Caring for Hospitalized Patients with Covid-19.
    N Engl J Med. 2022;387:e51.
    >> Share

  151. CHEMAITELLY H, AlMukdad S, Ayoub HH, Altarawneh HN, et al
    Covid-19 Vaccine Protection among Children and Adolescents in Qatar.
    N Engl J Med. 2022 Nov 2. doi: 10.1056/NEJMoa2210058.
    >> Share

    October 2022
  152. EMANUEL EJ, Upshur REG, Smith MJ
    What Covid Has Taught the World about Ethics.
    N Engl J Med. 2022;387:1542-1545.
    >> Share

  153. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Assessing the Effect of Vaccination and Prior SARS-CoV-2 Infection.
    N Engl J Med. 2022;387:e50.
    >> Share

  154. CHIN ET, Leidner D, Lamson L, Lucas K, et al
    Protection against Omicron from Vaccination and Previous Infection in a Prison System.
    N Engl J Med. 2022 Oct 26. doi: 10.1056/NEJMoa2207082.
    >> Share

  155. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Covid-19: Where Are We Heading?
    N Engl J Med. 2022;387:e47.
    >> Share

  156. ANDERSON EJ, Creech CB, Berthaud V, Piramzadian A, et al
    Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age.
    N Engl J Med. 2022 Oct 19. doi: 10.1056/NEJMoa2209367.
    >> Share

  157. WITBERG G, Magen O, Hoss S, Talmor-Barkan Y, et al
    Myocarditis after BNT162b2 Vaccination in Israeli Adolescents.
    N Engl J Med. 2022 Oct 19. doi: 10.1056/NEJMc2207270.
    >> Share

  158. HACHMANN NP, Miller J, Collier AY, Barouch DH, et al
    Neutralization Escape by SARS-CoV-2 Omicron Subvariant BA.4.6.
    N Engl J Med. 2022 Oct 19. doi: 10.1056/NEJMc2212117.
    >> Share

  159. RUBIN EJ, Baden LR, Neuzil KM, Morrissey S, et al
    Audio Interview: Developing New Covid-19 Vaccines.
    N Engl J Med. 2022;387:e44.
    >> Share

  160. CHEMAITELLY H, Ayoub HH, Tang P, Hasan MR, et al
    Immune Imprinting and Protection against Repeat Reinfection with SARS-CoV-2.
    N Engl J Med. 2022 Oct 12. doi: 10.1056/NEJMc2211055.
    >> Share

  161. ALTARAWNEH HN, Chemaitelly H, Ayoub HH, Hasan MR, et al
    Protective Effect of Previous SARS-CoV-2 Infection against Omicron BA.4 and BA.5 Subvariants.
    N Engl J Med. 2022 Oct 5. doi: 10.1056/NEJMc2209306.
    >> Share

    September 2022
  162. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Assessing Bivalent Vaccines against Covid-19.
    N Engl J Med. 2022;387:e37.
    >> Share

  163. TAKASHITA E, Yamayoshi S, Fukushi S, Suzuki T, et al
    Efficacy of Antiviral Agents against the Omicron Subvariant BA.2.75.
    N Engl J Med. 2022;387:1236-1238.
    >> Share

  164. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Can Vaccines Prevent Transmission of Covid-19?
    N Engl J Med. 2022;387:e30.
    >> Share

  165. THURNER L, Kessel C, Fadle N, Regitz E, et al
    IL-1RA Antibodies in Myocarditis after SARS-CoV-2 Vaccination.
    N Engl J Med. 2022 Sep 21. doi: 10.1056/NEJMc2205667.
    >> Share

  166. CHALKIAS S, Harper C, Vrbicky K, Walsh SR, et al
    A Bivalent Omicron-Containing Booster Vaccine against Covid-19.
    N Engl J Med. 2022 Sep 16. doi: 10.1056/NEJMoa2208343.
    >> Share

  167. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Developing Mucosal Immunity to Covid-19.
    N Engl J Med. 2022;387:e29.
    >> Share

  168. HAVERVALL S, Marking U, Svensson J, Greilert-Norin N, et al
    Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection.
    N Engl J Med. 2022 Sep 14. doi: 10.1056/NEJMc2209651.
    >> Share

  169. COLLIE S, Nayager J, Bamford L, Bekker LG, et al
    Effectiveness and Durability of the BNT162b2 Vaccine against Omicron Sublineages in South Africa.
    N Engl J Med. 2022 Sep 14. doi: 10.1056/NEJMc2210093.
    >> Share

  170. SHEN X, Chalkias S, Feng J, Chen X, et al
    Neutralization of SARS-CoV-2 Omicron BA.2.75 after mRNA-1273 Vaccination.
    N Engl J Med. 2022 Sep 9. doi: 10.1056/NEJMc2210648.
    >> Share

  171. SULLIVAN DJ, Gebo KA, Hanley DF
    Convalescent Plasma for Covid-19. Reply.
    N Engl J Med. 2022;387:955-956.
    >> Share

  172. PANETH N
    Convalescent Plasma for Covid-19.
    N Engl J Med. 2022;387:955.
    >> Share

  173. JOYNER MJ, Pirofski LA
    Convalescent Plasma for Covid-19.
    N Engl J Med. 2022;387:955.
    >> Share

  174. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Rolling Out New Covid-19 Vaccines.
    N Engl J Med. 2022;387:e26.
    >> Share

  175. CHARNESS ME, Gupta K, Stack G, Strymish J, et al
    Rebound of SARS-CoV-2 Infection after Nirmatrelvir-Ritonavir Treatment.
    N Engl J Med. 2022 Sep 7. doi: 10.1056/NEJMc2206449.
    >> Share

  176. ANDERSON AS, Caubel P, Rusnak JM
    Nirmatrelvir-Ritonavir and Viral Load Rebound in Covid-19.
    N Engl J Med. 2022 Sep 7. doi: 10.1056/NEJMc2205944.
    >> Share

  177. LIN DY, Gu Y, Xu Y, Zeng D, et al
    Effects of Vaccination and Previous Infection on Omicron Infections in Children.
    N Engl J Med. 2022 Sep 7. doi: 10.1056/NEJMc2209371.
    >> Share

  178. QU P, Faraone JN, Evans JP, Zheng YM, et al
    Durability of Booster mRNA Vaccine against SARS-CoV-2 BA.2.12.1, BA.4, and BA.5 Subvariants.
    N Engl J Med. 2022 Sep 7. doi: 10.1056/NEJMc2210546.
    >> Share

  179. DUPONT SC, Galea S
    Science, Competing Values, and Trade-offs in Public Health - The Example of Covid-19 and Masking.
    N Engl J Med. 2022 Sep 3. doi: 10.1056/NEJMp2207670.
    >> Share

  180. RUBIN EJ, Baden LR, Swaminathan S, Morrissey S, et al
    Audio Interview: Covid-19 and the WHO.
    N Engl J Med. 2022;387:e24.
    >> Share

    August 2022
  181. BAROUCH DH
    Covid-19 Vaccines - Immunity, Variants, Boosters.
    N Engl J Med. 2022 Aug 31. doi: 10.1056/NEJMra2206573.
    >> Share

  182. MALATO J, Ribeiro RM, Leite PP, Casaca P, et al
    Risk of BA.5 Infection among Persons Exposed to Previous SARS-CoV-2 Variants.
    N Engl J Med. 2022 Aug 31. doi: 10.1056/NEJMc2209479.
    >> Share

  183. MACDONALD SM, Berv J
    Losing Contact - Covid-19, Telemedicine, and the Patient-Provider Relationship.
    N Engl J Med. 2022 Aug 27. doi: 10.1056/NEJMp2206471.
    >> Share

  184. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Choosing an Antiviral to Treat Covid-19.
    N Engl J Med. 2022;387:e22.
    >> Share

  185. ARBEL R, Wolff Sagy Y, Hoshen M, Battat E, et al
    Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge.
    N Engl J Med. 2022 Aug 24. doi: 10.1056/NEJMoa2204919.
    >> Share

  186. ABDOOL KARIM SS, Devnarain N
    Time to Stop Using Ineffective Covid-19 Drugs.
    N Engl J Med. 2022;387:654-655.
    >> Share

  187. BRAMANTE CT, Huling JD, Tignanelli CJ, Buse JB, et al
    Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19.
    N Engl J Med. 2022;387:599-610.
    >> Share

  188. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Combating Covid-19 Today and Tomorrow.
    N Engl J Med. 2022;387:e17.
    >> Share

  189. JOST TS
    Considering Race and Ethnicity in Covid Risk Assessments - Legal Concerns and Possible Solutions.
    N Engl J Med. 2022;387:481-483.
    >> Share

  190. KOHANE I, Omenn GS
    Understanding Covid Vaccine Efficacy over Time - Bridging a Gap Between Public Health and Health Care.
    N Engl J Med. 2022 Aug 6. doi: 10.1056/NEJMp2201084.
    >> Share

  191. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Updated Covid-19 Vaccines and a Look at Monkeypox.
    N Engl J Med. 2022;387:e16.
    >> Share

  192. TAKASHITA E, Yamayoshi S, Simon V, van Bakel H, et al
    Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants.
    N Engl J Med. 2022;387:468-470.
    >> Share

    July 2022
  193. RUBIN EJ, Baden LR, Currier JS, Morrissey S, et al
    Audio Interview: Reinventing the Research Infrastructure to Address Covid-19.
    N Engl J Med. 2022;387:e13.
    >> Share

  194. RUBIN EJ, Baden LR, Jha A, Morrissey S, et al
    Audio Interview: A Look at the U.S. Government's Covid-19 Strategy.
    N Engl J Med. 2022;387:e11.
    >> Share

  195. HAMMOND J, Bao W, Simon-Campos A
    Nirmatrelvir for Nonhospitalized Adults with Covid-19. Reply.
    N Engl J Med. 2022;387.
    >> Share

  196. MORRIS AM, Lee TC
    Nirmatrelvir for Nonhospitalized Adults with Covid-19.
    N Engl J Med. 2022;387.
    >> Share

  197. CHEN BS, Hung CH, Wei JC
    Nirmatrelvir for Nonhospitalized Adults with Covid-19.
    N Engl J Med. 2022;387.
    >> Share

  198. TAN SHX, Cook AR, Heng D, Ong B, et al
    Effectiveness of BNT162b2 Vaccine against Omicron in Children 5 to 11 Years of Age.
    N Engl J Med. 2022 Jul 20. doi: 10.1056/NEJMoa2203209.
    >> Share

  199. MAIER HE, Balmaseda A, Saborio S, Ojeda S, et al
    Protection Associated with Previous SARS-CoV-2 Infection in Nicaragua.
    N Engl J Med. 2022 Jul 20. doi: 10.1056/NEJMc2203985.
    >> Share

  200. RUBIN EJ, Baden LR, Marks P, Morrissey S, et al
    Audio Interview: Covid-19 Vaccines and the FDA.
    N Engl J Med. 2022;387:e10.
    >> Share

  201. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Designing the Next Covid-19 Vaccine.
    N Engl J Med. 2022;387:e6.
    >> Share

  202. ZHAO X, Zhang R, Qiao S, Wang X, et al
    Omicron SARS-CoV-2 Neutralization from Inactivated and ZF2001 Vaccines.
    N Engl J Med. 2022 Jul 6. doi: 10.1056/NEJMc2206900.
    >> Share

    June 2022
  203. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: How Effective is Covid-19 Vaccination in Children?
    N Engl J Med. 2022;386:e78.
    >> Share

  204. WAXMAN JG, Magen O, Hernan MA
    Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine. Reply.
    N Engl J Med. 2022;387.
    >> Share

  205. TUMMINIA A, Romano M
    Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine.
    N Engl J Med. 2022;387.
    >> Share

  206. COHEN-STAVI CJ, Magen O, Barda N, Yaron S, et al
    BNT162b2 Vaccine Effectiveness against Omicron in Children 5 to 11 Years of Age.
    N Engl J Med. 2022 Jun 29. doi: 10.1056/NEJMoa2205011.
    >> Share

  207. BOUCAU J, Marino C, Regan J, Uddin R, et al
    Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection.
    N Engl J Med. 2022 Jun 29. doi: 10.1056/NEJMc2202092.
    >> Share

  208. LAUNAY O, Cachanado M, Luong Nguyen LB, Ninove L, et al
    Immunogenicity and Safety of Beta-Adjuvanted Recombinant Booster Vaccine.
    N Engl J Med. 2022 Jun 29. doi: 10.1056/NEJMc2206711.
    >> Share

  209. SCHONBORN L, Seck SE, Thiele T, Warkentin TE, et al
    SARS-CoV-2 Infection in Patients with a History of VITT.
    N Engl J Med. 2022 Jun 27. doi: 10.1056/NEJMc2206601.
    >> Share

  210. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Vaccinating Young Children against Covid-19.
    N Engl J Med. 2022;386:e77.
    >> Share

  211. GRIFFIN MR
    A Challenge to Respiratory Syncytial Virus Illness in Adults.
    N Engl J Med. 2022;386:2427-2428.
    >> Share

  212. SCHMOELE-THOMA B, Zareba AM, Jiang Q, Maddur MS, et al
    Vaccine Efficacy in Adults in a Respiratory Syncytial Virus Challenge Study.
    N Engl J Med. 2022;386:2377-2386.
    >> Share

  213. HACHMANN NP, Miller J, Collier AY, Ventura JD, et al
    Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5.
    N Engl J Med. 2022 Jun 22. doi: 10.1056/NEJMc2206576.
    >> Share

  214. DESILVA M, Haapala J, Vazquez-Benitez G, Vesco KK, et al
    Evaluation of Acute Adverse Events after Covid-19 Vaccination during Pregnancy.
    N Engl J Med. 2022 Jun 22. doi: 10.1056/NEJMc2205276.
    >> Share

  215. HALASA NB, Olson SM, Staat MA, Newhams MM, et al
    Maternal Vaccination and Risk of Hospitalization for Covid-19 among Infants.
    N Engl J Med. 2022 Jun 22. doi: 10.1056/NEJMoa2204399.
    >> Share

  216. RASMUSSEN SA, Jamieson DJ
    Covid-19 Vaccination during Pregnancy - Two for the Price of One.
    N Engl J Med. 2022 Jun 22. doi: 10.1056/NEJMe2206730.
    >> Share

  217. RUBIN EJ, Baden LR, Abraham J, Morrissey S, et al
    Audio Interview: Viral Evolution and the Future of Monoclonal Antibodies.
    N Engl J Med. 2022;386:e75.
    >> Share

  218. LEUCHTER RK, Jackson NJ, Mafi JN, Sarkisian CA, et al
    Association between Covid-19 Vaccination and Influenza Vaccination Rates.
    N Engl J Med. 2022 Jun 15. doi: 10.1056/NEJMc2204560.
    >> Share

  219. QU P, Faraone J, Evans JP, Zou X, et al
    Neutralization of the SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants.
    N Engl J Med. 2022 Jun 15. doi: 10.1056/NEJMc2206725.
    >> Share

  220. HOPKINS S, Hall V, Klenerman P
    Protection against SARS-CoV-2 after Vaccination and Previous Infection. Reply.
    N Engl J Med. 2022;386.
    >> Share

  221. MATUCHANSKY C
    Protection against SARS-CoV-2 after Vaccination and Previous Infection.
    N Engl J Med. 2022;386.
    >> Share

  222. ALTARAWNEH HN, Chemaitelly H, Ayoub HH, Tang P, et al
    Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections.
    N Engl J Med. 2022 Jun 15. doi: 10.1056/NEJMoa2203965.
    >> Share

  223. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Protecting the Immunocompromised from Covid-19.
    N Engl J Med. 2022;386:e71.
    >> Share

  224. ABRAHAM J
    Monoclonal Antibodies with Extended Half-Life to Prevent Covid-19.
    N Engl J Med. 2022;386:2236-2238.
    >> Share

  225. JOLOBE OMP
    Protection Due to Previous SARS-CoV-2 Infection.
    N Engl J Med. 2022;386.
    >> Share

  226. SCHERER EM, Babiker A, Adelman MW, Allman B, et al
    SARS-CoV-2 Evolution and Immune Escape in Immunocompromised Patients.
    N Engl J Med. 2022 Jun 8. doi: 10.1056/NEJMc2202861.
    >> Share

  227. RUBIN EJ, Baden LR, Moore PL, Morrissey S, et al
    Audio Interview: Dissecting the Host Response to SARS-CoV-2.
    N Engl J Med. 2022;386:e69.
    >> Share

    May 2022
  228. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Waning Immunity against Covid-19.
    N Engl J Med. 2022;386:e64.
    >> Share

  229. GOLDBERG Y, Mandel M, Bar-On YM, Bodenheimer O, et al
    Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2.
    N Engl J Med. 2022 May 25. doi: 10.1056/NEJMoa2118946.
    >> Share

  230. ACCORSI EK, Britton A, Shang N, Fleming-Dutra KE, et al
    Effectiveness of Homologous and Heterologous Covid-19 Boosters against Omicron.
    N Engl J Med. 2022 May 25. doi: 10.1056/NEJMc2203165.
    >> Share

  231. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: What to Make of Covid-19 Hot Spots.
    N Engl J Med. 2022;386:e63.
    >> Share

  232. BROWN PE, Fu SH, Bansal A, Newcombe L, et al
    Omicron BA.1/1.1 SARS-CoV-2 Infection among Vaccinated Canadian Adults.
    N Engl J Med. 2022 May 18. doi: 10.1056/NEJMc2202879.
    >> Share

  233. EVANS JP, Qu P, Zeng C, Zheng YM, et al
    Neutralization of the SARS-CoV-2 Deltacron and BA.3 Variants.
    N Engl J Med. 2022 May 18. doi: 10.1056/NEJMc2205019.
    >> Share

  234. RUBIN EJ, Baden LR, Lipsitch M, Morrissey S, et al
    Audio Interview: Forecasting the Future of Covid.
    N Engl J Med. 2022;386:e58.
    >> Share

  235. CREECH CB, Anderson E, Berthaud V, Yildirim I, et al
    Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age.
    N Engl J Med. 2022 May 11. doi: 10.1056/NEJMoa2203315.
    >> Share

  236. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Do We Need New Covid-19 Vaccines?
    N Engl J Med. 2022;386:e52.
    >> Share

  237. ESTCOURT L, Callum J
    Convalescent Plasma for Covid-19 - Making Sense of the Inconsistencies.
    N Engl J Med. 2022;386:1753-1754.
    >> Share

  238. HAGER KJ, Perez Marc G, Gobeil P, Diaz RS, et al
    Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine.
    N Engl J Med. 2022 May 4. doi: 10.1056/NEJMoa2201300.
    >> Share

  239. DAI L, Gao L, Tao L, Hadinegoro SR, et al
    Efficacy and Safety of the RBD-Dimer-Based Covid-19 Vaccine ZF2001 in Adults.
    N Engl J Med. 2022 May 4. doi: 10.1056/NEJMoa2202261.
    >> Share

  240. NOHYNEK H, Wilder-Smith A
    Does the World Still Need New Covid-19 Vaccines?
    N Engl J Med. 2022 May 4. doi: 10.1056/NEJMe2204695.
    >> Share

  241. GRAY G, Collie S, Goga A, Garrett N, et al
    Effectiveness of Ad26.COV2.S and BNT162b2 Vaccines against Omicron Variant in South Africa.
    N Engl J Med. 2022 May 4. doi: 10.1056/NEJMc2202061.
    >> Share

  242. PERSAD G, Pandya A
    A Comprehensive Covid-19 Response - The Need for Economic Evaluation.
    N Engl J Med. 2022 May 4. doi: 10.1056/NEJMp2202828.
    >> Share

    April 2022
  243. RUBIN EJ, Baden LR, Marrazzo JM, Morrissey S, et al
    Audio Interview: Communicating Covid-19 Science.
    N Engl J Med. 2022;386:e53.
    >> Share

  244. SIMOES EAF, Center KJ, Tita ATN, Swanson KA, et al
    Prefusion F Protein-Based Respiratory Syncytial Virus Immunization in Pregnancy.
    N Engl J Med. 2022;386:1615-1626.
    >> Share

  245. RUBIN EJ, Baden LR, Inglefinger JR, Morrissey S, et al
    Audio Interview: The Effects of Covid-19 on Children.
    N Engl J Med. 2022;386:e51.
    >> Share

  246. BHATTACHARYYA RP, Hanage WP
    Intrinsic Severity of the SARS-CoV-2 Omicron Variant. Reply.
    N Engl J Med. 2022 Apr 20. pii: 10.1056/NEJMc2203679.
    >> Share

  247. SHAFER SL
    Intrinsic Severity of the SARS-CoV-2 Omicron Variant.
    N Engl J Med. 2022 Apr 20. pii: 10.1056/NEJMc2203679.
    >> Share

  248. LEVIN MJ, Ustianowski A, De Wit S, Launay O, et al
    Intramuscular AZD7442 (Tixagevimab-Cilgavimab) for Prevention of Covid-19.
    N Engl J Med. 2022 Apr 20. doi: 10.1056/NEJMoa2116620.
    >> Share

  249. OFFIT PA
    Covid-19 Boosters - Where from Here?
    N Engl J Med. 2022 Apr 13. doi: 10.1056/NEJMe2203329.
    >> Share

  250. MAGEN O, Waxman JG, Makov-Assif M, Vered R, et al
    Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting.
    N Engl J Med. 2022 Apr 13. doi: 10.1056/NEJMoa2201688.
    >> Share

  251. DRAIN PK
    Rapid Diagnostic Testing for SARS-CoV-2. Reply.
    N Engl J Med. 2022;386.
    >> Share

  252. BOGATY P
    Rapid Diagnostic Testing for SARS-CoV-2.
    N Engl J Med. 2022;386.
    >> Share

  253. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Do We Need a Fourth Dose of Covid Vaccine?
    N Engl J Med. 2022;386:e45.
    >> Share

  254. MOORE PL, Baden LR
    Omicron - Decoupling Infection from Severe Disease.
    N Engl J Med. 2022;386:1361-1362.
    >> Share

  255. HORWITZ JR, Wiley LF
    Not Ready for the End Game - Why Ending Federal Covid-19 Emergency Declarations Will Harm Access to Care.
    N Engl J Med. 2022 Apr 6. doi: 10.1056/NEJMp2203468.
    >> Share

  256. YOON SK, Hegmann KT, Thiese MS, Burgess JL, et al
    Protection with a Third Dose of mRNA Vaccine against SARS-CoV-2 Variants in Frontline Workers.
    N Engl J Med. 2022 Apr 6. doi: 10.1056/NEJMc2201821.
    >> Share

  257. LEE KC, Morgan AU, Chaiyachati KH, Asch DA, et al
    Pulse Oximetry for Monitoring Patients with Covid-19 at Home - A Pragmatic, Randomized Trial.
    N Engl J Med. 2022 Apr 6. doi: 10.1056/NEJMc2201541.
    >> Share

  258. BAR-ON YM, Goldberg Y, Mandel M, Bodenheimer O, et al
    Protection by a Fourth Dose of BNT162b2 against Omicron in Israel.
    N Engl J Med. 2022 Apr 5. doi: 10.1056/NEJMoa2201570.
    >> Share

    March 2022
  259. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Effectiveness of Covid-19 Vaccination in Children.
    N Engl J Med. 2022;386:e39.
    >> Share

  260. KLEIN NP
    Added Benefit of Covid-19 Vaccination after Previous Infection.
    N Engl J Med. 2022;386:1278-1279.
    >> Share

  261. REIS G, Silva EASM, Silva DCM, Thabane L, et al
    Effect of Early Treatment with Ivermectin among Patients with Covid-19.
    N Engl J Med. 2022 Mar 30. doi: 10.1056/NEJMoa2115869.
    >> Share

  262. SULLIVAN DJ, Gebo KA, Shoham S, Bloch EM, et al
    Early Outpatient Treatment for Covid-19 with Convalescent Plasma.
    N Engl J Med. 2022 Mar 30. doi: 10.1056/NEJMoa2119657.
    >> Share

  263. PRICE AM, Olson SM, Newhams MM, Halasa NB, et al
    BNT162b2 Protection against the Omicron Variant in Children and Adolescents.
    N Engl J Med. 2022 Mar 30. doi: 10.1056/NEJMoa2202826.
    >> Share

  264. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Covid-19: Why We Publish What We Do.
    N Engl J Med. 2022;386:e38.
    >> Share

  265. VYAS JM, Castle AC, Bourgouin PP, Turbett SE, et al
    Case 9-2022: A 56-Year-Old Woman with Fever, Myalgias, Diarrhea, and Cough.
    N Engl J Med. 2022;386:1166-1174.
    >> Share

  266. ROSSLER A, Knabl L, von Laer D, Kimpel J, et al
    Neutralization Profile after Recovery from SARS-CoV-2 Omicron Infection.
    N Engl J Med. 2022 Mar 23. doi: 10.1056/NEJMc2201607.
    >> Share

  267. MOREIRA ED JR, Kitchin N, Xu X, Dychter SS, et al
    Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine.
    N Engl J Med. 2022 Mar 23. doi: 10.1056/NEJMoa2200674.
    >> Share

  268. QI X, Qiu H, Hao S, Zhu F, et al
    Human Infection with an Avian-Origin Influenza A (H10N3) Virus.
    N Engl J Med. 2022;386:1087-1088.
    >> Share

  269. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Can We Make More Effective Covid-19 Vaccines?
    N Engl J Med. 2022;386:e36.
    >> Share

  270. DE ANDA C, Johnson MG, Pedley A
    Molnupiravir for Covid-19 in Nonhospitalized Patients. Reply.
    N Engl J Med. 2022;386.
    >> Share

  271. ROBERFROID D, Jespers V, Hulstaert F
    Molnupiravir for Covid-19 in Nonhospitalized Patients.
    N Engl J Med. 2022;386.
    >> Share

  272. LEVENSTEIN S
    Molnupiravir for Covid-19 in Nonhospitalized Patients.
    N Engl J Med. 2022;386.
    >> Share

  273. SELVI-SABATER P, Abellon-Ruiz J
    Molnupiravir for Covid-19 in Nonhospitalized Patients.
    N Engl J Med. 2022;386.
    >> Share

  274. THORLUND K, Sheldrick K, Mills E
    Molnupiravir for Covid-19 in Nonhospitalized Patients.
    N Engl J Med. 2022;386.
    >> Share

  275. REGEV-YOCHAY G, Gonen T, Gilboa M, Mandelboim M, et al
    Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron.
    N Engl J Med. 2022 Mar 16. doi: 10.1056/NEJMc2202542.
    >> Share

  276. SHAPIRO AE, Gupta A
    Early Treatment with Sotrovimab for Covid-19. Reply.
    N Engl J Med. 2022 Mar 16. pii: 10.1056/NEJMc2201606.
    >> Share

  277. FUJIWARA Y
    Early Treatment with Sotrovimab for Covid-19.
    N Engl J Med. 2022 Mar 16. pii: 10.1056/NEJMc2201606.
    >> Share

  278. ORIGUEN J, Caro-Teller JM, Lopez-Medrano F
    Early Treatment with Sotrovimab for Covid-19.
    N Engl J Med. 2022 Mar 16. pii: 10.1056/NEJMc2201606.
    >> Share

  279. HATZL S, Krause R, Schilcher G
    Early Treatment with Sotrovimab for Covid-19.
    N Engl J Med. 2022 Mar 16. pii: 10.1056/NEJMc2201606.
    >> Share

  280. YU J, Collier AY, Rowe M, Mardas F, et al
    Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants.
    N Engl J Med. 2022 Mar 16. doi: 10.1056/NEJMc2201849.
    >> Share

  281. RUBIN EJ, Baden LR, Hunter D, Morrissey S, et al
    Audio Interview: Making Covid-19 Vaccines Available around the World.
    N Engl J Med. 2022;386:e31.
    >> Share

  282. TAKASHITA E, Kinoshita N, Yamayoshi S, Sakai-Tagawa Y, et al
    Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2.
    N Engl J Med. 2022 Mar 9. doi: 10.1056/NEJMc2201933.
    >> Share

  283. ROCKETT R, Basile K, Maddocks S, Fong W, et al
    Resistance Mutations in SARS-CoV-2 Delta Variant after Sotrovimab Use.
    N Engl J Med. 2022 Mar 9. doi: 10.1056/NEJMc2120219.
    >> Share

  284. ABU-RADDAD LJ, Chemaitelly H, Ayoub HH, AlMukdad S, et al
    Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar.
    N Engl J Med. 2022 Mar 9. doi: 10.1056/NEJMoa2200797.
    >> Share

  285. MONTO AS
    The Future of SARS-CoV-2 Vaccination. Reply.
    N Engl J Med. 2022;386:899-900.
    >> Share

  286. BACHMANN MF, Mohsen MO, Speiser DE
    The Future of SARS-CoV-2 Vaccination.
    N Engl J Med. 2022;386:899.
    >> Share

  287. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Using Our Covid-19 Experience to Develop Vaccines More Quickly.
    N Engl J Med. 2022;386:e29.
    >> Share

  288. DOMACHOWSKE J, Madhi SA, Simoes EAF, Atanasova V, et al
    Safety of Nirsevimab for RSV in Infants with Heart or Lung Disease or Prematurity.
    N Engl J Med. 2022;386:892-894.
    >> Share

  289. GEE JE, Bower WA, Kunkel A, Petras J, et al
    Multistate Outbreak of Melioidosis Associated with Imported Aromatherapy Spray.
    N Engl J Med. 2022;386:861-868.
    >> Share

  290. HAMMITT LL, Dagan R, Yuan Y, Baca Cots M, et al
    Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants.
    N Engl J Med. 2022;386:837-846.
    >> Share

  291. MELLO MM, Parmet WE
    U.S. Public Health Law - Foundations and Emerging Shifts.
    N Engl J Med. 2022;386:805-808.
    >> Share

  292. WALTER EB, Talaat KR, Gurtman A
    More on BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age. Reply.
    N Engl J Med. 2022;386.
    >> Share

  293. LEIBOWITZ R, Schurr E, Hirsch O
    More on BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age.
    N Engl J Med. 2022;386.
    >> Share

  294. TAYTARD J, Prevost B, Corvol H
    More on BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age.
    N Engl J Med. 2022;386.
    >> Share

  295. ANDREWS N, Stowe J, Kirsebom F, Toffa S, et al
    Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant.
    N Engl J Med. 2022 Mar 2. doi: 10.1056/NEJMoa2119451.
    >> Share

  296. SAVILLE M, Cramer JP, Downham M, Hacker A, et al
    Delivering Pandemic Vaccines in 100 Days - What Will It Take?
    N Engl J Med. 2022 Mar 2. doi: 10.1056/NEJMp2202669.
    >> Share

    February 2022
  297. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Understanding the Omicron Variant of SARS-CoV-2.
    N Engl J Med. 2022;386:e27.
    >> Share

  298. HUNTER DJ, Abdool Karim SS, Baden LR, Farrar JJ, et al
    Addressing Vaccine Inequity - Covid-19 Vaccines as a Global Public Good.
    N Engl J Med. 2022 Feb 23. doi: 10.1056/NEJMe2202547.
    >> Share

  299. MADHI SA, Kwatra G, Myers JE, Jassat W, et al
    Population Immunity and Covid-19 Severity with Omicron Variant in South Africa.
    N Engl J Med. 2022 Feb 23. doi: 10.1056/NEJMoa2119658.
    >> Share

  300. ANDERSON LJ, Walsh EE
    The Challenge of Respiratory Syncytial Virus Human Challenge Studies.
    N Engl J Med. 2022;386:696-697.
    >> Share

  301. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: A New Antiviral against Covid-19.
    N Engl J Med. 2022;386:e25.
    >> Share

  302. AHMAD A, Eze K, Noulin N, Horvathova V, et al
    EDP-938, a Respiratory Syncytial Virus Inhibitor, in a Human Virus Challenge.
    N Engl J Med. 2022;386:655-666.
    >> Share

  303. FLEISHER LA, Schreiber M, Cardo D, Srinivasan A, et al
    Health Care Safety during the Pandemic and Beyond - Building a System That Ensures Resilience.
    N Engl J Med. 2022;386:609-611.
    >> Share

  304. GOTTLIEB RL, Juneja K, Hill JA
    Outpatient Remdesivir to Prevent Progression to Severe Covid-19. Reply.
    N Engl J Med. 2022 Feb 16. pii: 10.1056/NEJMc2200591.
    >> Share

  305. ENNEZAT PV
    Outpatient Remdesivir to Prevent Progression to Severe Covid-19.
    N Engl J Med. 2022 Feb 16. pii: 10.1056/NEJMc2200591.
    >> Share

  306. HAMMERMAN A, Sergienko R, Friger M, Beckenstein T, et al
    Effectiveness of the BNT162b2 Vaccine after Recovery from Covid-19.
    N Engl J Med. 2022 Feb 16. doi: 10.1056/NEJMoa2119497.
    >> Share

  307. HALL V, Foulkes S, Insalata F, Kirwan P, et al
    Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection.
    N Engl J Med. 2022 Feb 16. doi: 10.1056/NEJMoa2118691.
    >> Share

  308. HAMMOND J, Leister-Tebbe H, Gardner A, Abreu P, et al
    Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19.
    N Engl J Med. 2022 Feb 16. doi: 10.1056/NEJMoa2118542.
    >> Share

  309. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Covid-19 as an Endemic Disease.
    N Engl J Med. 2022;386:e21.
    >> Share

  310. ARBEL R, Sergienko R, Hammerman A
    BNT162b2 Vaccine Booster and Covid-19 Mortality. Reply.
    N Engl J Med. 2022 Feb 9. pii: 10.1056/NEJMc2120044.
    >> Share

  311. SADOFF J, Gray G, Vandebosch A, Cardenas V, et al
    Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S.
    N Engl J Med. 2022 Feb 9. doi: 10.1056/NEJMoa2117608.
    >> Share

  312. PILZ S
    BNT162b2 Vaccine Booster and Covid-19 Mortality.
    N Engl J Med. 2022 Feb 9. pii: 10.1056/NEJMc2120044.
    >> Share

  313. ROHBAN T
    BNT162b2 Vaccine Booster and Covid-19 Mortality.
    N Engl J Med. 2022 Feb 9. pii: 10.1056/NEJMc2120044.
    >> Share

  314. ALTARAWNEH HN, Chemaitelly H, Hasan MR, Ayoub HH, et al
    Protection against the Omicron Variant from Previous SARS-CoV-2 Infection.
    N Engl J Med. 2022 Feb 9. doi: 10.1056/NEJMc2200133.
    >> Share

  315. MAYR FB, Talisa VB, Shaikh O, Yende S, et al
    Effectiveness of Homologous or Heterologous Covid-19 Boosters in Veterans.
    N Engl J Med. 2022 Feb 9. doi: 10.1056/NEJMc2200415.
    >> Share

  316. RUBIN EJ, Baden LR, Rosen CJ, Morrissey S, et al
    Audio Interview: Studying Long Covid.
    N Engl J Med. 2022;386:e20.
    >> Share

  317. BRAGA NETO MB, Badley AD, Parikh SA, Graham RP, et al
    Calm before the Storm.
    N Engl J Med. 2022;386:479-485.
    >> Share

  318. MURPHY WJ, Longo DL
    Anti-idiotype Antibodies in SARS-CoV-2 Infection and Vaccination. Reply.
    N Engl J Med. 2022 Feb 2. pii: 10.1056/NEJMc2119443.
    >> Share

  319. HARVILLE TO, Arthur JM
    Anti-idiotype Antibodies in SARS-CoV-2 Infection and Vaccination.
    N Engl J Med. 2022 Feb 2. pii: 10.1056/NEJMc2119443.
    >> Share

  320. DE MARIA A
    Anti-idiotype Antibodies in SARS-CoV-2 Infection and Vaccination.
    N Engl J Med. 2022 Feb 2. pii: 10.1056/NEJMc2119443.
    >> Share

  321. BHATTACHARYYA RP, Hanage WP
    Challenges in Inferring Intrinsic Severity of the SARS-CoV-2 Omicron Variant.
    N Engl J Med. 2022 Feb 2. doi: 10.1056/NEJMp2119682.
    >> Share

    January 2022
  322. RUBIN EJ, Baden LR, Barocas JA, Morrissey S, et al
    Audio Interview: Addressing the Omicron Variant of SARS-CoV-2.
    N Engl J Med. 2022;386:e16.
    >> Share

  323. TAKASHITA E, Kinoshita N, Yamayoshi S, Sakai-Tagawa Y, et al
    Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant.
    N Engl J Med. 2022 Jan 26. doi: 10.1056/NEJMc2119407.
    >> Share

  324. ABU-RADDAD LJ, Chemaitelly H, Bertollini R
    Waning mRNA-1273 Vaccine Effectiveness against SARS-CoV-2 Infection in Qatar.
    N Engl J Med. 2022 Jan 26. doi: 10.1056/NEJMc2119432.
    >> Share

  325. ROACH A, Chikwe J, Catarino P, Rampolla R, et al
    Lung Transplantation for Covid-19-Related Respiratory Failure in the United States.
    N Engl J Med. 2022 Jan 26. doi: 10.1056/NEJMc2117024.
    >> Share

  326. RUBIN EJ, Baden LR, Fineberg HV, Morrissey S, et al
    Audio Interview: Crushing the Covid-19 Curve.
    N Engl J Med. 2022;386:e13.
    >> Share

  327. WALTER EB, Talaat KR, Gurtman A
    BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age. Reply.
    N Engl J Med. 2022;386.
    >> Share

  328. MINTZKER Y
    BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age.
    N Engl J Med. 2022;386.
    >> Share

  329. FANG SF, Liu N, Du HW
    BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age.
    N Engl J Med. 2022;386.
    >> Share

  330. ABU-RADDAD LJ, Chemaitelly H, Bertollini R
    Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar.
    N Engl J Med. 2022 Jan 19. doi: 10.1056/NEJMc2117933.
    >> Share

  331. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Covid-19 Takeaways at Podcast 100.
    N Engl J Med. 2022;386:e11.
    >> Share

  332. WEINSTEIN DF
    Reengineering GME in a Pandemic - Looking Back, and Forward.
    N Engl J Med. 2022;386:97.
    >> Share

  333. ANDREWS N, Tessier E, Stowe J, Gower C, et al
    Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines.
    N Engl J Med. 2022 Jan 12. doi: 10.1056/NEJMoa2115481.
    >> Share

  334. EDWARDS KM
    Sparing of Severe Covid-19 in Vaccinated Adolescents.
    N Engl J Med. 2022 Jan 12. doi: 10.1056/NEJMe2118471.
    >> Share

  335. ROSSLER A, Riepler L, Bante D, von Laer D, et al
    SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons.
    N Engl J Med. 2022 Jan 12. doi: 10.1056/NEJMc2119236.
    >> Share

  336. OLSON SM, Newhams MM, Halasa NB, Price AM, et al
    Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents.
    N Engl J Med. 2022 Jan 12. doi: 10.1056/NEJMoa2117995.
    >> Share

  337. LIN DY, Gu Y, Wheeler B, Young H, et al
    Effectiveness of Covid-19 Vaccines over a 9-Month Period in North Carolina.
    N Engl J Med. 2022 Jan 12. doi: 10.1056/NEJMoa2117128.
    >> Share

  338. DRAIN PK
    Rapid Diagnostic Testing for SARS-CoV-2.
    N Engl J Med. 2022 Jan 7. doi: 10.1056/NEJMcp2117115.
    >> Share

  339. RUBIN EJ, Baden LR, Drosten C, Morrissey S, et al
    Audio Interview: Covid-19 - The Outlook in Europe.
    N Engl J Med. 2022;386:e9.
    >> Share

  340. GONEN T, Lustig Y, Regev-Yochay G
    Covid-19 Infections in Vaccinated Health Care Workers. Reply.
    N Engl J Med. 2022;386.
    >> Share

  341. RASTMANESH R
    Covid-19 Infections in Vaccinated Health Care Workers.
    N Engl J Med. 2022;386.
    >> Share

  342. EYRE DW, Taylor D, Purver M, Chapman D, et al
    Effect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants.
    N Engl J Med. 2022 Jan 5. doi: 10.1056/NEJMoa2116597.
    >> Share

  343. PAI M, Kasaeva T, Swaminathan S
    Covid-19's Devastating Effect on Tuberculosis Care - A Path to Recovery.
    N Engl J Med. 2022 Jan 5. doi: 10.1056/NEJMp2118145.
    >> Share

    December 2021
  344. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Covid-19 Vaccination and the Omicron Variant.
    N Engl J Med. 2021;385:e102.
    >> Share

  345. RITTENBERG E
    Trust, Faith, and Covid.
    N Engl J Med. 2021;385:2504-2505.
    >> Share

  346. SCHMIDT F, Muecksch F, Weisblum Y, Da Silva J, et al
    Plasma Neutralization of the SARS-CoV-2 Omicron Variant.
    N Engl J Med. 2021 Dec 30. doi: 10.1056/NEJMc2119641.
    >> Share

  347. MCGREW S, Taylor HA
    Adolescents, Parents, and Covid-19 Vaccination - Who Should Decide?
    N Engl J Med. 2021 Dec 29. doi: 10.1056/NEJMp2116771.
    >> Share

  348. NEMET I, Kliker L, Lustig Y, Zuckerman N, et al
    Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection.
    N Engl J Med. 2021 Dec 29. doi: 10.1056/NEJMc2119358.
    >> Share

  349. KISSLER SM, Fauver JR, Mack C, Tai CG, et al
    Viral Dynamics of SARS-CoV-2 Variants in Vaccinated and Unvaccinated Persons.
    N Engl J Med. 2021;385:2489-2491.
    >> Share

  350. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: A Potential New Agent to Treat Covid-19.
    N Engl J Med. 2021;385:e101.
    >> Share

  351. GENG LN, Verghese A, Tilburt JC
    Consultative Medicine - An Emerging Specialty for Patients with Perplexing Conditions.
    N Engl J Med. 2021;385:2478-2484.
    >> Share

  352. FOXWORTH R, Redvers N, Moreno MA, Lopez-Carmen VA, et al
    Covid-19 Vaccination in American Indians and Alaska Natives - Lessons from Effective Community Responses.
    N Engl J Med. 2021;385:2403-2406.
    >> Share

  353. GOTTLIEB RL, Vaca CE, Paredes R, Mera J, et al
    Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients.
    N Engl J Med. 2021 Dec 22. doi: 10.1056/NEJMoa2116846.
    >> Share

  354. MUHSEN K, Maimon N, Mizrahi A, Varticovschi B, et al
    Effects of BNT162b2 Covid-19 Vaccine Booster in Long-Term Care Facilities in Israel.
    N Engl J Med. 2021 Dec 22. doi: 10.1056/NEJMc2117385.
    >> Share

  355. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: How Much Protection Does Prior SARS-CoV-2 Infection Provide?
    N Engl J Med. 2021;385:e100.
    >> Share

  356. WHITLEY R
    Molnupiravir - A Step toward Orally Bioavailable Therapies for Covid-19.
    N Engl J Med. 2021 Dec 16. doi: 10.1056/NEJMe2117814.
    >> Share

  357. JAYK BERNAL A, Gomes da Silva MM, Musungaie DB, Kovalchuk E, et al
    Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients.
    N Engl J Med. 2021 Dec 16. doi: 10.1056/NEJMoa2116044.
    >> Share

  358. CHEMAITELLY H, Bertollini R, Abu-Raddad LJ
    Efficacy of Natural Immunity against SARS-CoV-2 Reinfection with the Beta Variant.
    N Engl J Med. 2021 Dec 15. doi: 10.1056/NEJMc2110300.
    >> Share

  359. HORTON LE, Abeles SR, Torriani FJ
    SARS-CoV-2 Infection in Vaccinated Health Care Workers. Reply.
    N Engl J Med. 2021 Dec 15. pii: 10.1056/NEJMc2117119.
    >> Share

  360. LILLERI D, Marena C, Baldanti F
    SARS-CoV-2 Infection in Vaccinated Health Care Workers.
    N Engl J Med. 2021 Dec 15. pii: 10.1056/NEJMc2117119.
    >> Share

  361. MORENS DM, Taubenberger JK, Fauci AS
    Universal Coronavirus Vaccines - An Urgent Need.
    N Engl J Med. 2021 Dec 15. doi: 10.1056/NEJMp2118468.
    >> Share

  362. DUNKLE LM, Kotloff KL, Gay CL, Anez G, et al
    Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico.
    N Engl J Med. 2021 Dec 15. doi: 10.1056/NEJMoa2116185.
    >> Share

  363. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Waning Immunity against SARS-CoV-2.
    N Engl J Med. 2021;385:e99.
    >> Share

  364. KNUDSEN J, Chokshi DA
    Covid-19 and the Safety Net - Moving from Straining to Sustaining.
    N Engl J Med. 2021;385:2209-2211.
    >> Share

  365. ARBEL R, Hammerman A, Sergienko R, Friger M, et al
    BNT162b2 Vaccine Booster and Mortality Due to Covid-19.
    N Engl J Med. 2021 Dec 8. doi: 10.1056/NEJMoa2115624.
    >> Share

  366. BAR-ON YM, Goldberg Y, Mandel M, Bodenheimer O, et al
    Protection against Covid-19 by BNT162b2 Booster across Age Groups.
    N Engl J Med. 2021 Dec 8. doi: 10.1056/NEJMoa2115926.
    >> Share

  367. WALKER AS, Vihta KD, Gethings O, Pritchard E, et al
    Tracking the Emergence of SARS-CoV-2 Alpha Variant in the United Kingdom.
    N Engl J Med. 2021 Dec 8. doi: 10.1056/NEJMc2103227.
    >> Share

  368. MCGARRY BE, Barnett ML, Grabowski DC, Gandhi AD, et al
    Nursing Home Staff Vaccination and Covid-19 Outcomes.
    N Engl J Med. 2021 Dec 8. doi: 10.1056/NEJMc2115674.
    >> Share

  369. RUBIN EJ, Baden LR, Abdool Karim SS, Morrissey S, et al
    Audio Interview: The Omicron Variant of SARS-CoV-2.
    N Engl J Med. 2021;385:e96.
    >> Share

  370. CAFORIO ALP
    Receipt of mRNA Vaccine against Covid-19 and Myocarditis.
    N Engl J Med. 2021;385:2189-2190.
    >> Share

  371. RUBIN EJ, Longo DL
    Covid-19 mRNA Vaccines - Six of One, Half a Dozen of the Other.
    N Engl J Med. 2021 Dec 1. doi: 10.1056/NEJMe2117446.
    >> Share

  372. ROSENBERG ES, Dorabawila V, Easton D, Bauer UE, et al
    Covid-19 Vaccine Effectiveness in New York State.
    N Engl J Med. 2021 Dec 1. doi: 10.1056/NEJMoa2116063.
    >> Share

  373. DICKERMAN BA, Gerlovin H, Madenci AL, Kurgansky KE, et al
    Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines in U.S. Veterans.
    N Engl J Med. 2021 Dec 1. doi: 10.1056/NEJMoa2115463.
    >> Share

    November 2021
  374. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: What's Gone Right in Our Battle against Covid-19.
    N Engl J Med. 2021;385:e95.
    >> Share

  375. ABU-RADDAD LJ, Chemaitelly H, Bertollini R
    Severity of SARS-CoV-2 Reinfections as Compared with Primary Infections.
    N Engl J Med. 2021 Nov 24. doi: 10.1056/NEJMc2108120.
    >> Share

  376. MURPHY WJ, Longo DL
    A Possible Role for Anti-idiotype Antibodies in SARS-CoV-2 Infection and Vaccination.
    N Engl J Med. 2021 Nov 24. doi: 10.1056/NEJMcibr2113694.
    >> Share

  377. ZARYCHANSKI R, Lawler PR, Goligher E
    Therapeutic Anticoagulation with Heparin in Patients with Covid-19. Reply.
    N Engl J Med. 2021;385:2014.
    >> Share

  378. FERNANDES TM, McGuire WC, Morris TA
    Therapeutic Anticoagulation with Heparin in Patients with Covid-19.
    N Engl J Med. 2021;385:2013.
    >> Share

  379. STERPETTI AV
    Therapeutic Anticoagulation with Heparin in Patients with Covid-19.
    N Engl J Med. 2021;385:2013-2014.
    >> Share

  380. RUBIN EJ, Baden LR, Mello MM, Morrissey S, et al
    Audio Interview: The Legal Basis for Covid-19 Restrictions and Mandates.
    N Engl J Med. 2021;385:e88.
    >> Share

  381. RUBIN EJ, Baden LR, Grinsztejn B, Morrissey S, et al
    Audio Interview: Covid-19 in Brazil and New Evidence for Vaccinating Younger Children.
    N Engl J Med. 2021;385:e79.
    >> Share

  382. LOPEZ BERNAL J, Gower C, Andrews N
    Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant. Reply.
    N Engl J Med. 2021 Nov 10. pii: 10.1056/NEJMc2113090.
    >> Share

  383. EMANI VR, Reddy R, Goswami S
    Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.
    N Engl J Med. 2021 Nov 10. pii: 10.1056/NEJMc2113090.
    >> Share

  384. LINSENMEYER K, Gupta K, Charness ME
    Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.
    N Engl J Med. 2021 Nov 10. pii: 10.1056/NEJMc2113090.
    >> Share

  385. TORGOVNICK J
    Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.
    N Engl J Med. 2021 Nov 10. pii: 10.1056/NEJMc2113090.
    >> Share

  386. MONTO AS
    The Future of SARS-CoV-2 Vaccination - Lessons from Influenza.
    N Engl J Med. 2021 Nov 6. doi: 10.1056/NEJMp2113403.
    >> Share

  387. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Do We Have the Tools to End the Covid-19 Pandemic?
    N Engl J Med. 2021;385:e78.
    >> Share

  388. SCULLY M
    VITT after ChAdOx1 nCoV-19 Vaccination. Reply.
    N Engl J Med. 2021 Nov 3. pii: 10.1056/NEJMc2111026.
    >> Share

  389. GREINACHER A, Schonborn L, Thiele T
    VITT after ChAdOx1 nCoV-19 Vaccination. Reply.
    N Engl J Med. 2021 Nov 3. pii: 10.1056/NEJMc2111026.
    >> Share

  390. WEBER C, von Hundelshausen P, Siess W
    VITT after ChAdOx1 nCoV-19 Vaccination.
    N Engl J Med. 2021 Nov 3. pii: 10.1056/NEJMc2111026.
    >> Share

  391. SANTIN AD
    VITT after ChAdOx1 nCoV-19 Vaccination.
    N Engl J Med. 2021 Nov 3. pii: 10.1056/NEJMc2111026.
    >> Share

  392. URIU K, Kimura I, Shirakawa K, Takaori-Kondo A, et al
    Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum.
    N Engl J Med. 2021 Nov 3. doi: 10.1056/NEJMc2114706.
    >> Share

    October 2021
  393. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: A New Monoclonal Antibody for Covid-19 and Potential Vaccination for Children.
    N Engl J Med. 2021;385:e74.
    >> Share

  394. CHIN MH
    Uncomfortable Truths - What Covid-19 Has Revealed about Chronic-Disease Care in America.
    N Engl J Med. 2021;385:1633-1636.
    >> Share

  395. ASKENASE PW
    Rare Skin Reactions after mRNA Vaccination, Similar to Jones-Mote Basophil Responses.
    N Engl J Med. 2021;385:1720-1721.
    >> Share

  396. GUPTA A, Gonzalez-Rojas Y, Juarez E, Crespo Casal M, et al
    Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab.
    N Engl J Med. 2021 Oct 27. doi: 10.1056/NEJMoa2107934.
    >> Share

  397. GOLDBERG Y, Mandel M, Bar-On YM, Bodenheimer O, et al
    Waning Immunity after the BNT162b2 Vaccine in Israel.
    N Engl J Med. 2021 Oct 27. doi: 10.1056/NEJMoa2114228.
    >> Share

  398. DAGAN N, Barda N, Balicer RD
    Adverse Effects after BNT162b2 Vaccine and SARS-CoV-2 Infection, According to Age and Sex.
    N Engl J Med. 2021 Oct 27. doi: 10.1056/NEJMc2115045.
    >> Share

  399. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: A New Look at Covid-19 Vaccine Boosters.
    N Engl J Med. 2021;385:e72.
    >> Share

  400. MALLETT SD
    Peak Moments - When Kindergarten Is High Risk.
    N Engl J Med. 2021;385:1543-1545.
    >> Share

  401. MAGNUS MC, Gjessing HK, Eide HN, Wilcox AJ, et al
    Covid-19 Vaccination during Pregnancy and First-Trimester Miscarriage.
    N Engl J Med. 2021 Oct 20. doi: 10.1056/NEJMc2114466.
    >> Share

  402. TEMPLE C, Hoang R, Hendrickson RG
    Toxic Effects from Ivermectin Use Associated with Prevention and Treatment of Covid-19.
    N Engl J Med. 2021 Oct 20. doi: 10.1056/NEJMc2114907.
    >> Share

  403. CHIN ET, Leidner D, Zhang Y, Long E, et al
    Effectiveness of the mRNA-1273 Vaccine during a SARS-CoV-2 Delta Outbreak in a Prison.
    N Engl J Med. 2021 Oct 20. doi: 10.1056/NEJMc2114089.
    >> Share

  404. SHEIKH A, Robertson C, Taylor B
    BNT162b2 and ChAdOx1 nCoV-19 Vaccine Effectiveness against Death from the Delta Variant.
    N Engl J Med. 2021 Oct 20. doi: 10.1056/NEJMc2113864.
    >> Share

  405. REIS BY, Barda N, Leshchinsky M, Kepten E, et al
    Effectiveness of BNT162b2 Vaccine against Delta Variant in Adolescents.
    N Engl J Med. 2021 Oct 20. doi: 10.1056/NEJMc2114290.
    >> Share

  406. NOLAN T, Fortanier AC, Leav B, Poder A, et al
    Efficacy of a Cell-Culture-Derived Quadrivalent Influenza Vaccine in Children.
    N Engl J Med. 2021;385:1485-1495.
    >> Share

  407. RUBIN EJ, Baden LR, Wu KJ, Morrissey S, et al
    Audio Interview: Reporting on Covid-19.
    N Engl J Med. 2021;385:e66.
    >> Share

  408. HOCK H, Kelly HR, Meyerowitz EA, Frigault MJ, et al
    Case 31-2021: A 21-Year-Old Man with Sore Throat, Epistaxis, and Oropharyngeal Petechiae.
    N Engl J Med. 2021;385:1511-1520.
    >> Share

  409. BALSARI S, Kiang MV, Buckee CO
    Data in Crisis - Rethinking Disaster Preparedness in the United States.
    N Engl J Med. 2021;385:1526-1530.
    >> Share

  410. WHITE EM, Mor V
    SARS-CoV-2 Infection among Nursing Home Residents. Reply.
    N Engl J Med. 2021 Oct 13. pii: 10.1056/NEJMc2114113.
    >> Share

  411. CHANDRASEKAR B
    SARS-CoV-2 Infection among Nursing Home Residents.
    N Engl J Med. 2021 Oct 13. pii: 10.1056/NEJMc2114113.
    >> Share

  412. KORLEY FK, Durkalski-Mauldin V, Callaway CW
    Convalescent Plasma for Outpatients with Covid-19. Reply.
    N Engl J Med. 2021 Oct 13. pii: 10.1056/NEJMc2114591.
    >> Share

  413. SCHULZ E
    Convalescent Plasma for Outpatients with Covid-19.
    N Engl J Med. 2021 Oct 13. pii: 10.1056/NEJMc2114591.
    >> Share

  414. FISHER D, Malnick S
    Convalescent Plasma for Outpatients with Covid-19.
    N Engl J Med. 2021 Oct 13. pii: 10.1056/NEJMc2114591.
    >> Share

  415. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Are Covid-19 Vaccine Boosters Necessary?
    N Engl J Med. 2021;385:e63.
    >> Share

  416. THOMPSON MG, Grant L, Meece J
    Prevention of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines. Reply.
    N Engl J Med. 2021 Oct 6. pii: 10.1056/NEJMc2113575.
    >> Share

  417. ZHANG C, Yin G
    Prevention of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.
    N Engl J Med. 2021 Oct 6. pii: 10.1056/NEJMc2113575.
    >> Share

  418. SCHOOLEY RT
    Prevention of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.
    N Engl J Med. 2021 Oct 6. pii: 10.1056/NEJMc2113575.
    >> Share

  419. SANTACATTERINA M, Sanders JW, Weintraub WS
    Prevention of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.
    N Engl J Med. 2021 Oct 6. pii: 10.1056/NEJMc2113575.
    >> Share

  420. O'BRIEN MP, Hou P, Weinreich DM
    Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19. Reply.
    N Engl J Med. 2021 Oct 6. pii: 10.1056/NEJMc2113862.
    >> Share

  421. MERISON T, Goldman A, Bomze D
    Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.
    N Engl J Med. 2021 Oct 6. pii: 10.1056/NEJMc2113862.
    >> Share

  422. WITBERG G, Barda N, Hoss S, Richter I, et al
    Myocarditis after Covid-19 Vaccination in a Large Health Care Organization.
    N Engl J Med. 2021 Oct 6. doi: 10.1056/NEJMoa2110737.
    >> Share

  423. MEVORACH D, Anis E, Cedar N, Bromberg M, et al
    Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel.
    N Engl J Med. 2021 Oct 6. doi: 10.1056/NEJMoa2109730.
    >> Share

  424. CHEMAITELLY H, Tang P, Hasan MR, AlMukdad S, et al
    Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar.
    N Engl J Med. 2021 Oct 6. doi: 10.1056/NEJMoa2114114.
    >> Share

  425. LEVIN EG, Lustig Y, Cohen C, Fluss R, et al
    Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months.
    N Engl J Med. 2021 Oct 6. doi: 10.1056/NEJMoa2114583.
    >> Share

    September 2021
  426. RUBIN EJ, Baden LR, Tofel R, Morrissey S, et al
    Audio Interview: Covid-19 and the Media.
    N Engl J Med. 2021;385:e59.
    >> Share

  427. RAPEPORT G, Chiu C, McShane H
    SARS-CoV-2 Human Challenge Studies. Reply.
    N Engl J Med. 2021 Sep 29. pii: 10.1056/NEJMc2113574.
    >> Share

  428. STEUWER B, Eyal N
    SARS-CoV-2 Human Challenge Studies.
    N Engl J Med. 2021 Sep 29. pii: 10.1056/NEJMc2113574.
    >> Share

  429. WEINREICH DM, Sivapalasingam S, Norton T, Ali S, et al
    REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19.
    N Engl J Med. 2021 Sep 29. doi: 10.1056/NEJMoa2108163.
    >> Share

  430. FALSEY AR, Sobieszczyk ME, Hirsch I, Sproule S, et al
    Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine.
    N Engl J Med. 2021 Sep 29. doi: 10.1056/NEJMoa2105290.
    >> Share

  431. AMIT S, Gonen T, Regev-Yochay G
    Covid-19 Breakthrough Infections in Vaccinated Health Care Workers. Reply.
    N Engl J Med. 2021;385.
    >> Share

  432. JUNG J, Sung H, Kim SH
    Covid-19 Breakthrough Infections in Vaccinated Health Care Workers.
    N Engl J Med. 2021;385.
    >> Share

  433. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Vaccine Efficacy and Boosters in Covid-19.
    N Engl J Med. 2021;385:e54.
    >> Share

  434. ESSEX R, Weldon SM
    Health Care Worker Strikes and the Covid Pandemic. Reply.
    N Engl J Med. 2021;385:e43.
    >> Share

  435. CHAN SSC
    Health Care Worker Strikes and the Covid Pandemic.
    N Engl J Med. 2021;385:e43.
    >> Share

  436. SON MBF, Newburger JW, Randolph AG
    Therapy for Multisystem Inflammatory Syndrome in Children. Reply.
    N Engl J Med. 2021;385:e42.
    >> Share

  437. MCARDLE AJ, Cunnington AJ, Levin M
    Therapy for Multisystem Inflammatory Syndrome in Children. Reply.
    N Engl J Med. 2021;385:e42.
    >> Share

  438. OULDALI N, Belot A, Angoulvant F
    Therapy for Multisystem Inflammatory Syndrome in Children.
    N Engl J Med. 2021;385:e42.
    >> Share

  439. HARLEY JB
    Therapy for Multisystem Inflammatory Syndrome in Children.
    N Engl J Med. 2021;385:e42.
    >> Share

  440. JONES DS, Podolsky SH
    Mask Wars.
    N Engl J Med. 2021;385:1159-1161.
    >> Share

  441. EL SAHLY HM, Baden LR, Essink B, Doblecki-Lewis S, et al
    Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase.
    N Engl J Med. 2021 Sep 22. doi: 10.1056/NEJMoa2113017.
    >> Share

  442. PILISHVILI T, Gierke R, Fleming-Dutra KE, Farrar JL, et al
    Effectiveness of mRNA Covid-19 Vaccine among U.S. Health Care Personnel.
    N Engl J Med. 2021 Sep 22. doi: 10.1056/NEJMoa2106599.
    >> Share

  443. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: New Evidence on SARS-CoV-2 Vaccine Boosters.
    N Engl J Med. 2021;385:e48.
    >> Share

  444. NORTH CS, Sorg EM, Youn S, Chu JT, et al
    Case 28-2021: A 37-Year-Old Woman with Covid-19 and Suicidal Ideation.
    N Engl J Med. 2021;385:1125-1132.
    >> Share

  445. FRENCK RW JR, Dormitzer PR, Gurtman A
    BNT162b2 Covid-19 Vaccine in Adolescents. Reply.
    N Engl J Med. 2021;385.
    >> Share

  446. LIN CH
    BNT162b2 Covid-19 Vaccine in Adolescents.
    N Engl J Med. 2021;385.
    >> Share

  447. JARA A, Undurraga EA, Araos R
    Effectiveness of an Inactivated SARS-CoV-2 Vaccine. Reply.
    N Engl J Med. 2021;385.
    >> Share

  448. ONISHI FJ, Goto JM
    Effectiveness of an Inactivated SARS-CoV-2 Vaccine.
    N Engl J Med. 2021;385.
    >> Share

  449. CHI H, Chiu NC, Lin CY
    Effectiveness of an Inactivated SARS-CoV-2 Vaccine.
    N Engl J Med. 2021;385.
    >> Share

  450. OKHOTIN A
    Effectiveness of an Inactivated SARS-CoV-2 Vaccine.
    N Engl J Med. 2021;385.
    >> Share

  451. BAR-ON YM, Goldberg Y, Mandel M, Bodenheimer O, et al
    Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel.
    N Engl J Med. 2021 Sep 15. doi: 10.1056/NEJMoa2114255.
    >> Share

  452. FALSEY AR, Frenck RW Jr, Walsh EE, Kitchin N, et al
    SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3.
    N Engl J Med. 2021 Sep 15. doi: 10.1056/NEJMc2113468.
    >> Share

  453. THOMAS SJ, Moreira ED Jr, Kitchin N, Absalon J, et al
    Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months.
    N Engl J Med. 2021 Sep 15. doi: 10.1056/NEJMoa2110345.
    >> Share

  454. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Protecting against Severe Disease and Transmission.
    N Engl J Med. 2021;385:e44.
    >> Share

  455. MEANEY-DELMAN DM, Ellington SR, Shimabukuro TT
    On Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons. Reply.
    N Engl J Med. 2021 Sep 8. pii: 10.1056/NEJMc2113516.
    >> Share

  456. SUN H
    On Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons.
    N Engl J Med. 2021 Sep 8. pii: 10.1056/NEJMc2113516.
    >> Share

  457. DEAN NE, Hogan JW, Schnitzer ME
    Covid-19 Vaccine Effectiveness and the Test-Negative Design.
    N Engl J Med. 2021 Sep 8. doi: 10.1056/NEJMe2113151.
    >> Share

  458. THOMPSON MG, Stenehjem E, Grannis S, Ball SW, et al
    Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings.
    N Engl J Med. 2021 Sep 8. doi: 10.1056/NEJMoa2110362.
    >> Share

  459. SHAH ASV, Gribben C, Bishop J, Hanlon P, et al
    Effect of Vaccination on Transmission of SARS-CoV-2.
    N Engl J Med. 2021 Sep 8. doi: 10.1056/NEJMc2106757.
    >> Share

  460. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: A New Round of Rising Covid-19 Numbers.
    N Engl J Med. 2021;385:e41.
    >> Share

  461. WILDER-SMITH A, Mulholland K
    Effectiveness of an Inactivated SARS-CoV-2 Vaccine.
    N Engl J Med. 2021;385:946-948.
    >> Share

  462. WERNER RM, Glied SA
    Covid-Induced Changes in Health Care Delivery - Can They Last?
    N Engl J Med. 2021;385:868-870.
    >> Share

  463. KEEHNER J, Horton LE, Binkin NJ, Laurent LC, et al
    Resurgence of SARS-CoV-2 Infection in a Highly Vaccinated Health System Workforce.
    N Engl J Med. 2021 Sep 1. doi: 10.1056/NEJMc2112981.
    >> Share

  464. MELLO MM, Parmet WE
    Public Health Law after Covid-19.
    N Engl J Med. 2021 Sep 1. doi: 10.1056/NEJMp2112193.
    >> Share

    August 2021
  465. LEVY JH, Connors JM
    Heparin Resistance - Clinical Perspectives and Management Strategies.
    N Engl J Med. 2021;385:826-832.
    >> Share

  466. PAPINENI P
    A Pink Salwar.
    N Engl J Med. 2021;385:774-775.
    >> Share

  467. LEE GM
    The Importance of Context in Covid-19 Vaccine Safety.
    N Engl J Med. 2021 Aug 25. doi: 10.1056/NEJMe2112543.
    >> Share

  468. BARDA N, Dagan N, Ben-Shlomo Y, Kepten E, et al
    Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting.
    N Engl J Med. 2021 Aug 25. doi: 10.1056/NEJMoa2110475.
    >> Share

  469. UZUN G, Althaus K, Bakchoul T
    No Correlation between Anti-PF4 and Anti-SARS-CoV-2 Antibodies after ChAdOx1 nCoV-19 Vaccination.
    N Engl J Med. 2021 Aug 25. doi: 10.1056/NEJMc2111305.
    >> Share

  470. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Aspects of Covid-19 Immunity.
    N Engl J Med. 2021;385:e31.
    >> Share

  471. ROSAS IO, Raby B, Tsai L
    Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19. Reply.
    N Engl J Med. 2021 Aug 18. pii: 10.1056/NEJMc2108482.
    >> Share

  472. GORDON AC, Angus DC, Derde LPG
    Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19. Reply.
    N Engl J Med. 2021 Aug 18. pii: 10.1056/NEJMc2108482.
    >> Share

  473. BROWN MJ, Alazawi W, Kanoni S
    Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.
    N Engl J Med. 2021 Aug 18. pii: 10.1056/NEJMc2108482.
    >> Share

  474. TAN CW, Chia WN, Young BE, Zhu F, et al
    Pan-Sarbecovirus Neutralizing Antibodies in BNT162b2-Immunized SARS-CoV-1 Survivors.
    N Engl J Med. 2021 Aug 18. doi: 10.1056/NEJMoa2108453.
    >> Share

  475. KORLEY FK, Durkalski-Mauldin V, Yeatts SD, Schulman K, et al
    Early Convalescent Plasma for High-Risk Outpatients with Covid-19.
    N Engl J Med. 2021 Aug 18. doi: 10.1056/NEJMoa2103784.
    >> Share

  476. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Monoclonal Antibodies and Booster Shots.
    N Engl J Med. 2021;385:e29.
    >> Share

  477. BARAS SHREIBATI J
    When Low Tech Wins.
    N Engl J Med. 2021;385:581-583.
    >> Share

  478. PHILLIPS S, Williams MA
    Confronting Our Next National Health Disaster - Long-Haul Covid.
    N Engl J Med. 2021;385:577-579.
    >> Share

  479. WILLIAMS WW, Ingelfinger JR
    Third Time's a Charm - Covid-19 Vaccine Hope for Solid-Organ Transplant Recipients.
    N Engl J Med. 2021 Aug 11. doi: 10.1056/NEJMe2112866.
    >> Share

  480. PAVORD S, Scully M, Hunt BJ, Lester W, et al
    Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis.
    N Engl J Med. 2021 Aug 11. doi: 10.1056/NEJMoa2109908.
    >> Share

  481. ALI K, Berman G, Zhou H, Deng W, et al
    Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents.
    N Engl J Med. 2021 Aug 11. doi: 10.1056/NEJMoa2109522.
    >> Share

  482. HALL VG, Ferreira VH, Ku T, Ierullo M, et al
    Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients.
    N Engl J Med. 2021 Aug 11. doi: 10.1056/NEJMc2111462.
    >> Share

  483. COREY L, Beyrer C, Cohen MS, Michael NL, et al
    SARS-CoV-2 Variants in Patients with Immunosuppression.
    N Engl J Med. 2021;385:562-566.
    >> Share

  484. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Looking Back and Looking Forward - Part 2.
    N Engl J Med. 2021;385:e25.
    >> Share

  485. GOLIGHER EC, Bradbury CA, McVerry BJ, Lawler PR, et al
    Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.
    N Engl J Med. 2021 Aug 4. doi: 10.1056/NEJMoa2103417.
    >> Share

  486. LAWLER PR, Goligher EC, Berger JS, Neal MD, et al
    Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
    N Engl J Med. 2021 Aug 4. doi: 10.1056/NEJMoa2105911.
    >> Share

  487. TEN CATE H
    Surviving Covid-19 with Heparin?
    N Engl J Med. 2021 Aug 4. doi: 10.1056/NEJMe2111151.
    >> Share

  488. O'BRIEN MP, Forleo-Neto E, Musser BJ, Isa F, et al
    Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.
    N Engl J Med. 2021 Aug 4. doi: 10.1056/NEJMoa2109682.
    >> Share

    July 2021
  489. GUIMARAES PO, Quirk D, Furtado RH, Maia LN, et al
    Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia.
    N Engl J Med. 2021;385:406-415.
    >> Share

  490. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Looking Back and Looking Forward - Part 1.
    N Engl J Med. 2021;385:e24.
    >> Share

  491. BERGWERK M, Gonen T, Lustig Y, Amit S, et al
    Covid-19 Breakthrough Infections in Vaccinated Health Care Workers.
    N Engl J Med. 2021 Jul 28. doi: 10.1056/NEJMoa2109072.
    >> Share

  492. RUBIN EJ, Baden LR, Armstrong KA, Morrissey S, et al
    Audio Interview: The Impact of Covid-19 on Trainees and Junior Faculty.
    N Engl J Med. 2021;385:e21.
    >> Share

  493. MADHI SA, Izu A, Pollard AJ
    ChAdOx1 nCoV-19 Vaccine Efficacy against the B.1.351 Variant. Reply.
    N Engl J Med. 2021;385.
    >> Share

  494. STRUYF F, Sadoff J, Douoguih M
    ChAdOx1 nCoV-19 Vaccine Efficacy against the B.1.351 Variant.
    N Engl J Med. 2021;385.
    >> Share

  495. LOPEZ BERNAL J, Andrews N, Gower C, Gallagher E, et al
    Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.
    N Engl J Med. 2021 Jul 21. doi: 10.1056/NEJMoa2108891.
    >> Share

  496. RAPEPORT G, Smith E, Gilbert A, Catchpole A, et al
    SARS-CoV-2 Human Challenge Studies - Establishing the Model during an Evolving Pandemic.
    N Engl J Med. 2021 Jul 21. doi: 10.1056/NEJMp2106970.
    >> Share

  497. CHU VT, Yousaf AR, Chang K, Schwartz NG, et al
    Household Transmission of SARS-CoV-2 from Children and Adolescents.
    N Engl J Med. 2021 Jul 21. doi: 10.1056/NEJMc2031915.
    >> Share

  498. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Monoclonal Antibodies and Vaccine Boosts.
    N Engl J Med. 2021;385:e18.
    >> Share

  499. NORMARK J, Vikstrom L, Gwon YD, Persson IL, et al
    Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination.
    N Engl J Med. 2021 Jul 14. doi: 10.1056/NEJMc2110716.
    >> Share

  500. DOUGAN M, Nirula A, Azizad M, Mocherla B, et al
    Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.
    N Engl J Med. 2021 Jul 14. doi: 10.1056/NEJMoa2102685.
    >> Share

  501. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: How Well Are Covid-19 Vaccines Working?
    N Engl J Med. 2021;385:e15.
    >> Share

  502. EDARA VV, Pinsky BA, Suthar MS, Lai L, et al
    Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.
    N Engl J Med. 2021 Jul 7. doi: 10.1056/NEJMc2107799.
    >> Share

  503. BRINKLEY-RUBINSTEIN L, Peterson M, Martin R, Chan P, et al
    Breakthrough SARS-CoV-2 Infections in Prison after Vaccination.
    N Engl J Med. 2021 Jul 7. doi: 10.1056/NEJMc2108479.
    >> Share

  504. JARA A, Undurraga EA, Gonzalez C, Paredes F, et al
    Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile.
    N Engl J Med. 2021 Jul 7. doi: 10.1056/NEJMoa2107715.
    >> Share

  505. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Another New Covid-19 Vaccine.
    N Engl J Med. 2021;385:e13.
    >> Share

  506. SON MBF, Murray N, Friedman K, Young CC, et al
    Multisystem Inflammatory Syndrome in Children - Initial Therapy and Outcomes.
    N Engl J Med. 2021;385:23-34.
    >> Share

  507. MCARDLE AJ, Vito O, Patel H, Seaby EG, et al
    Treatment of Multisystem Inflammatory Syndrome in Children.
    N Engl J Med. 2021;385:11-22.
    >> Share

    June 2021
  508. THOMPSON MG, Burgess JL, Naleway AL, Tyner H, et al
    Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.
    N Engl J Med. 2021 Jun 30. doi: 10.1056/NEJMoa2107058.
    >> Share

  509. HEATH PT, Galiza EP, Baxter DN, Boffito M, et al
    Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.
    N Engl J Med. 2021 Jun 30. doi: 10.1056/NEJMoa2107659.
    >> Share

  510. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: A New mRNA Vaccine.
    N Engl J Med. 2021;384:e109.
    >> Share

  511. KRAUSE PR, Fleming TR, Longini IM, Peto R, et al
    SARS-CoV-2 Variants and Vaccines.
    N Engl J Med. 2021 Jun 23. doi: 10.1056/NEJMsr2105280.
    >> Share

  512. KAMAR N, Abravanel F, Marion O, Couat C, et al
    Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients.
    N Engl J Med. 2021 Jun 23. doi: 10.1056/NEJMc2108861.
    >> Share

  513. HARRIS RJ, Hall JA, Zaidi A, Andrews NJ, et al
    Effect of Vaccination on Household Transmission of SARS-CoV-2 in England.
    N Engl J Med. 2021 Jun 23. doi: 10.1056/NEJMc2107717.
    >> Share

  514. KOENIG PA, Schmidt FI
    Spike D614G - A Candidate Vaccine Antigen Against Covid-19.
    N Engl J Med. 2021;384:2349-2351.
    >> Share

  515. RILEY LE
    mRNA Covid-19 Vaccines in Pregnant Women.
    N Engl J Med. 2021;384:2342-2343.
    >> Share

  516. JAGSI R, Fuentes-Afflick E, Higginbotham E
    Promoting Equity for Women in Medicine - Seizing a Disruptive Opportunity.
    N Engl J Med. 2021;384:2265-2267.
    >> Share

  517. HIBBERT KA, Goiffon RJ, Fogerty AE
    Case 18-2021: An 81-Year-Old Man with Cough, Fever, and Shortness of Breath.
    N Engl J Med. 2021;384:2332-2340.
    >> Share

  518. ESSEX R, Weldon SM
    Health Care Worker Strikes and the Covid Pandemic.
    N Engl J Med. 2021;384:e93.
    >> Share

  519. RUBIN EJ, Baden LR, Ingelfinger JR, Morrissey S, et al
    Audio Interview: Covid-19 in Children.
    N Engl J Med. 2021;384:e108.
    >> Share

  520. VANDEBOSCH A, Sadoff J, Douoguih M
    Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19. Reply.
    N Engl J Med. 2021 Jun 9. pii: 10.1056/NEJMc2107809.
    >> Share

  521. HEININGER U
    Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.
    N Engl J Med. 2021 Jun 9. pii: 10.1056/NEJMc2107809.
    >> Share

  522. SAMARAKOON U, Alvarez-Arango S, Blumenthal KG
    Delayed Large Local Reactions to mRNA Covid-19 Vaccines in Blacks, Indigenous Persons, and People of Color.
    N Engl J Med. 2021 Jun 9. doi: 10.1056/NEJMc2108620.
    >> Share

  523. BECKER SJ, Taylor J, Sharfstein JM
    Identifying and Tracking SARS-CoV-2 Variants - A Challenge and an Opportunity.
    N Engl J Med. 2021 Jun 9. doi: 10.1056/NEJMp2103859.
    >> Share

  524. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Vaccinating Children.
    N Engl J Med. 2021;384:e103.
    >> Share

  525. BLACHERE NE, Hacisuleyman E, Darnell RB
    Vaccine Breakthrough Infections with SARS-CoV-2 Variants. Reply.
    N Engl J Med. 2021 Jun 2. pii: 10.1056/NEJMc2107808.
    >> Share

  526. RANA K, Mohindra R, Pinnaka L
    Vaccine Breakthrough Infections with SARS-CoV-2 Variants.
    N Engl J Med. 2021 Jun 2. pii: 10.1056/NEJMc2107808.
    >> Share

  527. NIXON DF, Ndhlovu LC
    Vaccine Breakthrough Infections with SARS-CoV-2 Variants.
    N Engl J Med. 2021 Jun 2. pii: 10.1056/NEJMc2107808.
    >> Share

    May 2021
  528. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Protecting the Immunosuppressed against Covid-19.
    N Engl J Med. 2021;384:e88.
    >> Share

  529. BURRIS S, Anderson ED, Wagenaar AC
    The "Legal Epidemiology" of Pandemic Control.
    N Engl J Med. 2021;384:1973-1975.
    >> Share

  530. FRENCK RW JR, Klein NP, Kitchin N, Gurtman A, et al
    Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents.
    N Engl J Med. 2021 May 27. doi: 10.1056/NEJMoa2107456.
    >> Share

  531. VOLPP KG, Cannuscio CC
    Incentives for Immunity - Strategies for Increasing Covid-19 Vaccine Uptake.
    N Engl J Med. 2021 May 26. doi: 10.1056/NEJMp2107719.
    >> Share

  532. SPARROW AK, Brosseau LM, Harrison RJ, Osterholm MT, et al
    Protecting Olympic Participants from Covid-19 - The Urgent Need for a Risk-Management Approach.
    N Engl J Med. 2021 May 25. doi: 10.1056/NEJMp2108567.
    >> Share

  533. RUBIN EJ, Baden LR, Drazen JM, Taichman DB, et al
    Audio Interview: Vaccination in Nursing Homes and New Pulmonary/Critical Care Research.
    N Engl J Med. 2021;384:e89.
    >> Share

  534. O'CONNELL J, O'Keeffe DT
    Contact Tracing for Covid-19 - A Digital Inoculation against Future Pandemics.
    N Engl J Med. 2021 May 19. doi: 10.1056/NEJMp2102256.
    >> Share

  535. WHITE EM, Yang X, Blackman C, Feifer RA, et al
    Incident SARS-CoV-2 Infection among mRNA-Vaccinated and Unvaccinated Nursing Home Residents.
    N Engl J Med. 2021 May 19. doi: 10.1056/NEJMc2104849.
    >> Share

  536. RUBIN EJ, Baden LR, Gray GE, Morrissey S, et al
    Audio Interview: Vaccination and Variants in the U.S. and South Africa.
    N Engl J Med. 2021;384:e85.
    >> Share

  537. RODRIGUEZ-HERNANDEZ M, Pilato TC, Yerdon KA, Kysel IM, et al
    Detained.
    N Engl J Med. 2021;384:1785-1787.
    >> Share

  538. WAPPNER D, Bergel E, Polack FP
    Plasma Therapy to Prevent Severe Covid-19 in Older Adults. Reply.
    N Engl J Med. 2021 May 12. pii: 10.1056/NEJMc2104747.
    >> Share

  539. RAGUSA M, Tortosa F, Izcovich A
    Plasma Therapy to Prevent Severe Covid-19 in Older Adults.
    N Engl J Med. 2021 May 12. pii: 10.1056/NEJMc2104747.
    >> Share

  540. KLAMT F, Parsons RB, Jones MH
    Plasma Therapy to Prevent Severe Covid-19 in Older Adults.
    N Engl J Med. 2021 May 12. pii: 10.1056/NEJMc2104747.
    >> Share

  541. KEEHNER J, Abeles SR, Torriani FJ
    More on SARS-CoV-2 Infection after Vaccination in Health Care Workers. Reply.
    N Engl J Med. 2021 May 12. pii: 10.1056/NEJMc2106004.
    >> Share

  542. LIU Y, Liu J, Xia H, Zhang X, et al
    BNT162b2-Elicited Neutralization against New SARS-CoV-2 Spike Variants.
    N Engl J Med. 2021 May 12. doi: 10.1056/NEJMc2106083.
    >> Share

  543. SCALES D, Gorman J, Jamieson KH
    The Covid-19 Infodemic - Applying the Epidemiologic Model to Counter Misinformation.
    N Engl J Med. 2021 May 12. doi: 10.1056/NEJMp2103798.
    >> Share

  544. RUBIN EJ, Baden LR, Udwadia ZF, Morrissey S, et al
    Audio Interview: India's Covid-19 Crisis.
    N Engl J Med. 2021;384:e84.
    >> Share

  545. SALWA J, Robertson C
    Designing an Independent Public Health Agency.
    N Engl J Med. 2021;384:1684-1687.
    >> Share

  546. NEUZIL KM
    Interplay between Emerging SARS-CoV-2 Variants and Pandemic Control.
    N Engl J Med. 2021 May 5. doi: 10.1056/NEJMe2103931.
    >> Share

  547. SHINDE V, Bhikha S, Hoosain Z, Archary M, et al
    Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant.
    N Engl J Med. 2021 May 5. doi: 10.1056/NEJMoa2103055.
    >> Share

  548. RATZAN S, Schneider EC, Hatch H, Cacchione J, et al
    Missing the Point - How Primary Care Can Overcome Covid-19 Vaccine "Hesitancy".
    N Engl J Med. 2021 May 5. doi: 10.1056/NEJMp2106137.
    >> Share

  549. ABU-RADDAD LJ, Chemaitelly H, Butt AA
    Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants.
    N Engl J Med. 2021 May 5. doi: 10.1056/NEJMc2104974.
    >> Share

    April 2021
  550. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Advice for Clinicians on Covid-19 Vaccines and Social Restrictions.
    N Engl J Med. 2021;384:e77.
    >> Share

  551. KADAKIA KT, Beckman AL, Ross JS, Krumholz HM, et al
    Leveraging Open Science to Accelerate Research.
    N Engl J Med. 2021;384:e61.
    >> Share

  552. GOLDFARB JL, Kreps S, Brownstein JS, Kriner DL, et al
    Beyond the First Dose - Covid-19 Vaccine Follow-through and Continued Protective Measures.
    N Engl J Med. 2021 Apr 28. doi: 10.1056/NEJMp2104527.
    >> Share

  553. FAJGENBAUM DC, June CH
    Cytokine Storm. Reply.
    N Engl J Med. 2021;384:e59.
    >> Share

  554. MUDD PA, Crawford JC, Thomas PG
    Cytokine Storm.
    N Engl J Med. 2021;384:e59.
    >> Share

  555. SUPADY A, Bode C, Duerschmied D
    Cytokine Storm.
    N Engl J Med. 2021;384:e59.
    >> Share

  556. GAESTEL M, Nebreda AR, Yaffe MB
    Cytokine Storm.
    N Engl J Med. 2021;384:e59.
    >> Share

  557. RUBIN EJ, Baden LR, Walensky RP, Morrissey S, et al
    Audio Interview: Covid-19 Vaccines and Pregnancy - A Conversation with CDC Director Rochelle Walensky.
    N Engl J Med. 2021;384:e73.
    >> Share

  558. DODD LE, Freidlin B, Korn EL
    Platform Trials - Beware the Noncomparable Control Group.
    N Engl J Med. 2021;384:1572-1573.
    >> Share

  559. CANELLI R, Shrestha GS, Ortega R
    Emergency Intubation in Covid-19. Reply.
    N Engl J Med. 2021;384.
    >> Share

  560. PATEL J, Janapala RN, Pourmand A
    Emergency Intubation in Covid-19.
    N Engl J Med. 2021;384.
    >> Share

  561. SELLERS WFS
    Emergency Intubation in Covid-19.
    N Engl J Med. 2021;384.
    >> Share

  562. HERZOG N, Giacardi C, Danguy des Deserts M
    Emergency Intubation in Covid-19.
    N Engl J Med. 2021;384.
    >> Share

  563. BARDA N, Dagan N, Balicer RD
    BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. Reply.
    N Engl J Med. 2021;384.
    >> Share

  564. ROEST S, Hoek RAS, Manintveld OC
    BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.
    N Engl J Med. 2021;384.
    >> Share

  565. BAECK M, Marot L, Belkhir L
    Delayed Large Local Reactions to mRNA Vaccines.
    N Engl J Med. 2021 Apr 21. pii: 10.1056/NEJMc2104751.
    >> Share

  566. SADOFF J, Gray G, Vandebosch A, Cardenas V, et al
    Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.
    N Engl J Med. 2021 Apr 21. doi: 10.1056/NEJMoa2101544.
    >> Share

  567. HACISULEYMAN E, Hale C, Saito Y, Blachere NE, et al
    Vaccine Breakthrough Infections with SARS-CoV-2 Variants.
    N Engl J Med. 2021 Apr 21. doi: 10.1056/NEJMoa2105000.
    >> Share

  568. CINES DB, Bussel JB
    SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.
    N Engl J Med. 2021 Apr 16. doi: 10.1056/NEJMe2106315.
    >> Share

  569. SCULLY M, Singh D, Lown R, Poles A, et al
    Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination.
    N Engl J Med. 2021 Apr 16. doi: 10.1056/NEJMoa2105385.
    >> Share

  570. MECKLAI K, Smith N, Stern AD, Kramer DB, et al
    Remote Patient Monitoring - Overdue or Overused?
    N Engl J Med. 2021;384:1384-1386.
    >> Share

  571. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Vaccine Successes and Vaccine Adverse Events.
    N Engl J Med. 2021;384:e70.
    >> Share

  572. LIU Y, Liu J, Xia H, Zhang X, et al
    Neutralizing Activity of BNT162b2-Elicited Serum.
    N Engl J Med. 2021;384:1466-1468.
    >> Share

  573. ANICHINI G, Terrosi C, Gandolfo C, Gori Savellini G, et al
    SARS-CoV-2 Antibody Response in Persons with Past Natural Infection.
    N Engl J Med. 2021 Apr 14. doi: 10.1056/NEJMc2103825.
    >> Share

  574. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Antibody Responses to Natural Infection and Vaccination.
    N Engl J Med. 2021;384:e65.
    >> Share

  575. SASISEKHARAN R
    Preparing for the Future - Nanobodies for Covid-19?
    N Engl J Med. 2021 Apr 7. doi: 10.1056/NEJMcibr2101205.
    >> Share

  576. MOYO-GWETE T, Madzivhandila M, Makhado Z, Ayres F, et al
    Cross-Reactive Neutralizing Antibody Responses Elicited by SARS-CoV-2 501Y.V2 (B.1.351).
    N Engl J Med. 2021 Apr 7. doi: 10.1056/NEJMc2104192.
    >> Share

  577. LUSTIG Y, Nemet I, Kliker L, Zuckerman N, et al
    Neutralizing Response against Variants after SARS-CoV-2 Infection and One Dose of BNT162b2.
    N Engl J Med. 2021 Apr 7. doi: 10.1056/NEJMc2104036.
    >> Share

  578. SHEN X, Tang H, Pajon R, Smith G, et al
    Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351.
    N Engl J Med. 2021 Apr 7. doi: 10.1056/NEJMc2103740.
    >> Share

  579. KIM MC, Park MS, Chung JW
    Viable SARS-CoV-2 Shedding. Reply.
    N Engl J Med. 2021;384.
    >> Share

  580. ROMANO CM, Felix AC, Pannuti CS
    Viable SARS-CoV-2 Shedding.
    N Engl J Med. 2021;384.
    >> Share

  581. DORIA-ROSE N, Suthar MS, Makowski M, O'Connell S, et al
    Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19.
    N Engl J Med. 2021 Apr 6. doi: 10.1056/NEJMc2103916.
    >> Share

  582. WANG GL, Wang ZY, Duan LJ, Meng QC, et al
    Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization.
    N Engl J Med. 2021 Apr 6. doi: 10.1056/NEJMc2103022.
    >> Share

  583. ELIAS C, Nkengasong JN, Qadri F
    Emerging Infectious Diseases - Learning from the Past and Looking to the Future.
    N Engl J Med. 2021;384:1181-1184.
    >> Share

  584. RUBIN EJ, Baden LR, Del Rio C, Akusobi C, et al
    Audio Interview: Delivering Covid-19 Vaccines to Minority Communities.
    N Engl J Med. 2021;384:e60.
    >> Share

    March 2021
  585. QUINN SC, Andrasik MP
    Addressing Vaccine Hesitancy in BIPOC Communities - Toward Trustworthiness, Partnership, and Reciprocity.
    N Engl J Med. 2021 Mar 31. doi: 10.1056/NEJMp2103104.
    >> Share

  586. NACHEGA JB, Sam-Agudu NA, Mellors JW, Zumla A, et al
    Scaling Up Covid-19 Vaccination in Africa - Lessons from the HIV Pandemic.
    N Engl J Med. 2021 Mar 31. doi: 10.1056/NEJMp2103313.
    >> Share

  587. HALL MA, Studdert DM
    "Vaccine Passport" Certification - Policy and Ethical Considerations.
    N Engl J Med. 2021 Mar 31. doi: 10.1056/NEJMp2104289.
    >> Share

  588. RUBIN EJ, Baden LR, Brandt AM, Morrissey S, et al
    Audio Interview: What Earlier Epidemics Teach Us about Covid-19.
    N Engl J Med. 2021;384:e55.
    >> Share

  589. KADIRE SR, Fabre V, Wenzel RP
    Doctor, How Long Should I Isolate?
    N Engl J Med. 2021;384:e47.
    >> Share

  590. ONI-ORISAN A, Mavura Y, Banda Y, Thornton TA, et al
    Embracing Genetic Diversity to Improve Black Health.
    N Engl J Med. 2021;384:1163-1167.
    >> Share

  591. ABDOOL KARIM SS, de Oliveira T
    New SARS-CoV-2 Variants - Clinical, Public Health, and Vaccine Implications.
    N Engl J Med. 2021 Mar 24. doi: 10.1056/NEJMc2100362.
    >> Share

  592. ARMSTRONG K
    Covid-19 and the Investigator Pipeline.
    N Engl J Med. 2021 Mar 24. doi: 10.1056/NEJMp2100086.
    >> Share

  593. KEEHNER J, Horton LE, Pfeffer MA, Longhurst CA, et al
    SARS-CoV-2 Infection after Vaccination in Health Care Workers in California.
    N Engl J Med. 2021 Mar 23. doi: 10.1056/NEJMc2101927.
    >> Share

  594. BENENSON S, Oster Y, Cohen MJ, Nir-Paz R, et al
    BNT162b2 mRNA Covid-19 Vaccine Effectiveness among Health Care Workers.
    N Engl J Med. 2021 Mar 23. doi: 10.1056/NEJMc2101951.
    >> Share

  595. DANIEL W, Nivet M, Warner J, Podolsky DK, et al
    Early Evidence of the Effect of SARS-CoV-2 Vaccine at One Medical Center.
    N Engl J Med. 2021 Mar 23. doi: 10.1056/NEJMc2102153.
    >> Share

  596. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Efficacy of Current Covid-19 Vaccines against Variant Viruses.
    N Engl J Med. 2021;384:e53.
    >> Share

  597. WU K, Werner AP, Koch M, Choi A, et al
    Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine.
    N Engl J Med. 2021 Mar 17. doi: 10.1056/NEJMc2102179.
    >> Share

  598. KRUTIKOV M, Hayward A, Shallcross L
    Spread of a Variant SARS-CoV-2 in Long-Term Care Facilities in England.
    N Engl J Med. 2021 Mar 16. doi: 10.1056/NEJMc2035906.
    >> Share

  599. MADHI SA, Baillie V, Cutland CL, Voysey M, et al
    Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant.
    N Engl J Med. 2021 Mar 16. doi: 10.1056/NEJMoa2102214.
    >> Share

  600. CARTER S
    Breathless.
    N Engl J Med. 2021;384:891-893.
    >> Share

  601. RUBIN EJ, Baden LR, Abraham J, Morrissey S, et al
    Audio Interview: The Implications of Changes in the Structural Biology of SARS-CoV-2.
    N Engl J Med. 2021;384:e48.
    >> Share

  602. POOLE MK, Fleischhacker SE, Bleich SN
    Addressing Child Hunger When School Is Closed - Considerations during the Pandemic and Beyond.
    N Engl J Med. 2021;384:e35.
    >> Share

  603. KRAMMER F, Srivastava K, Alshammary H, Amoako AA, et al
    Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine.
    N Engl J Med. 2021 Mar 10. doi: 10.1056/NEJMc2101667.
    >> Share

  604. GORALNICK E, Kaufmann C, Gawande AA
    Mass-Vaccination Sites - An Essential Innovation to Curb the Covid-19 Pandemic.
    N Engl J Med. 2021 Mar 10. doi: 10.1056/NEJMp2102535.
    >> Share

  605. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: A New SARS-CoV-2 Vaccine and a New Look at Treatment.
    N Engl J Med. 2021;384:e46.
    >> Share

  606. GOLETTI D, Cantini F
    Baricitinib Therapy in Covid-19 Pneumonia - An Unmet Need Fulfilled.
    N Engl J Med. 2021;384:867-869.
    >> Share

  607. BLUMENTHAL KG, Freeman EE, Saff RR, Robinson LB, et al
    Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2.
    N Engl J Med. 2021 Mar 3. doi: 10.1056/NEJMc2102131.
    >> Share

  608. STONE JH
    Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia. Reply.
    N Engl J Med. 2021 Mar 3. pii: 10.1056/NEJMc2100217.
    >> Share

  609. SALAMA C, Mohan SV
    Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia. Reply.
    N Engl J Med. 2021 Mar 3. pii: 10.1056/NEJMc2100217.
    >> Share

  610. LUNDH A
    Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia.
    N Engl J Med. 2021 Mar 3. pii: 10.1056/NEJMc2100217.
    >> Share

  611. STEELFISHER GK, Blendon RJ, Caporello H
    An Uncertain Public - Encouraging Acceptance of Covid-19 Vaccines.
    N Engl J Med. 2021 Mar 3. doi: 10.1056/NEJMp2100351.
    >> Share

  612. BARSKY BA, Reinhart E, Farmer P, Keshavjee S, et al
    Vaccination plus Decarceration - Stopping Covid-19 in Jails and Prisons.
    N Engl J Med. 2021 Mar 3. doi: 10.1056/NEJMp2100609.
    >> Share

  613. KRAMER DB, Opel DJ, Parasidis E, Mello MM, et al
    Choices in a Crisis - Individual Preferences among SARS-CoV-2 Vaccines.
    N Engl J Med. 2021 Mar 3. doi: 10.1056/NEJMp2102146.
    >> Share

  614. LUDVIGSSON JF
    Open Schools, Covid-19, and Child and Teacher Morbidity in Sweden. Reply.
    N Engl J Med. 2021 Mar 1. pii: 10.1056/NEJMc2101280.
    >> Share

  615. BESANCON L, Steadson D, Flahault A
    Open Schools, Covid-19, and Child and Teacher Morbidity in Sweden.
    N Engl J Med. 2021 Mar 1. pii: 10.1056/NEJMc2101280.
    >> Share

  616. TAKEFUJI Y
    Open Schools, Covid-19, and Child and Teacher Morbidity in Sweden.
    N Engl J Med. 2021 Mar 1. pii: 10.1056/NEJMc2101280.
    >> Share

    February 2021
  617. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: The Real-World Effectiveness of Covid-19 Vaccination.
    N Engl J Med. 2021;384:e40.
    >> Share

  618. NORMAND ST
    The RECOVERY Platform.
    N Engl J Med. 2021;384:757-758.
    >> Share

  619. LANE HC, Fauci AS
    Research in the Context of a Pandemic.
    N Engl J Med. 2021;384:755-757.
    >> Share

  620. MEHROTRA A, Nimgaonkar A, Richman B
    Telemedicine and Medical Licensure - Potential Paths for Reform.
    N Engl J Med. 2021;384:687-690.
    >> Share

  621. VAIS S
    The Inequity of Isolation.
    N Engl J Med. 2021;384:690-691.
    >> Share

  622. ROSAS IO, Brau N, Waters M, Go RC, et al
    Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia.
    N Engl J Med. 2021 Feb 25. doi: 10.1056/NEJMoa2028700.
    >> Share

  623. GORDON AC, Mouncey PR, Al-Beidh F, Rowan KM, et al
    Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.
    N Engl J Med. 2021 Feb 25. doi: 10.1056/NEJMoa2100433.
    >> Share

  624. RUBIN EJ, Longo DL, Baden LR
    Interleukin-6 Receptor Inhibition in Covid-19 - Cooling the Inflammatory Soup.
    N Engl J Med. 2021 Feb 25. doi: 10.1056/NEJMe2103108.
    >> Share

  625. DAGAN N, Barda N, Kepten E, Miron O, et al
    BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.
    N Engl J Med. 2021 Feb 24. doi: 10.1056/NEJMoa2101765.
    >> Share

  626. RUBIN EJ, Baden LR, Farrar JJ, Morrissey S, et al
    Audio Interview: Viral Variants and Covid-19.
    N Engl J Med. 2021;384:e38.
    >> Share

  627. SHRESTHA GS, Shrestha N, Lamsal R, Pradhan S, et al
    Emergency Intubation in Covid-19.
    N Engl J Med. 2021;384:e20.
    >> Share

  628. KADIRE SR, Wachter RM, Lurie N
    Delayed Second Dose versus Standard Regimen for Covid-19 Vaccination.
    N Engl J Med. 2021 Feb 17. doi: 10.1056/NEJMclde2101987.
    >> Share

  629. ABSALON J, Koury K, Gruber WC
    Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. Reply.
    N Engl J Med. 2021;384.
    >> Share

  630. WANG X
    Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
    N Engl J Med. 2021;384.
    >> Share

  631. VERGNES JN
    Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
    N Engl J Med. 2021;384.
    >> Share

  632. SKOWRONSKI DM, De Serres G
    Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
    N Engl J Med. 2021;384.
    >> Share

  633. ROSENBAUM L
    Escaping Catch-22 - Overcoming Covid Vaccine Hesitancy.
    N Engl J Med. 2021 Feb 12. doi: 10.1056/NEJMms2101220.
    >> Share

  634. HARRINGTON DP, Baden LR, Hogan JW
    A Large, Simple Trial Leading to Complex Questions.
    N Engl J Med. 2021;384:576-577.
    >> Share

  635. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Does Vaccination Mean the End of Masking and Social Distancing?
    N Engl J Med. 2021;384:e32.
    >> Share

  636. HORBY P, White NJ, Landray MJ
    Hydroxychloroquine in Hospitalized Patients with Covid-19. Reply.
    N Engl J Med. 2021;384.
    >> Share

  637. LACOUT A, Perronne C, Lounnas V
    Hydroxychloroquine in Hospitalized Patients with Covid-19.
    N Engl J Med. 2021;384.
    >> Share

  638. CASTELLS MC, Phillips EJ
    Maintaining Safety with SARS-CoV-2 Vaccines. Reply.
    N Engl J Med. 2021 Feb 10. pii: 10.1056/NEJMc2100766.
    >> Share

  639. ROLLA G, Brussino L, Badiu I
    Maintaining Safety with SARS-CoV-2 Vaccines.
    N Engl J Med. 2021 Feb 10. pii: 10.1056/NEJMc2100766.
    >> Share

  640. KASPER MR, Geibe JR
    An Outbreak of Covid-19 on an Aircraft Carrier. Reply.
    N Engl J Med. 2021;384.
    >> Share

  641. BYLICKI O, Paleiron N, Janvier F
    An Outbreak of Covid-19 on an Aircraft Carrier.
    N Engl J Med. 2021;384.
    >> Share

  642. RUBIN EJ, Baden LR, Northam RS, Morrissey S, et al
    Audio Interview: Covid-19 and the States - A Conversation with Ralph Northam.
    N Engl J Med. 2021;384:e25.
    >> Share

  643. WYLLIE AL, Vogels CBF, Grubaugh ND
    Saliva for Detection of SARS-CoV-2. Reply.
    N Engl J Med. 2021;384.
    >> Share

  644. MARKEWITZ RDH, Wandinger KP, Junker R
    Saliva for Detection of SARS-CoV-2.
    N Engl J Med. 2021;384.
    >> Share

  645. LUNDGREN JD, Lane HC, Neaton JD
    Monoclonal Antibody for Patients with Covid-19. Reply.
    N Engl J Med. 2021 Feb 3. pii: 10.1056/NEJMc2100221.
    >> Share

  646. JAWORSKI JP
    Monoclonal Antibody for Patients with Covid-19.
    N Engl J Med. 2021 Feb 3. pii: 10.1056/NEJMc2100221.
    >> Share

    January 2021
  647. RUBIN EJ, Baden LR, Fauci AS, Morrissey S, et al
    Audio Interview: A Covid-19 Conversation with Anthony Fauci.
    N Engl J Med. 2021;384:e22.
    >> Share

  648. HEATON PM
    The Covid-19 Vaccine-Development Multiverse. Reply.
    N Engl J Med. 2021;384.
    >> Share

  649. KOJIMA N, Turner I, Klausner JD
    The Covid-19 Vaccine-Development Multiverse.
    N Engl J Med. 2021;384.
    >> Share

  650. KIM MC, Cui C, Shin KR, Bae JY, et al
    Duration of Culturable SARS-CoV-2 in Hospitalized Patients with Covid-19.
    N Engl J Med. 2021 Jan 27. doi: 10.1056/NEJMc2027040.
    >> Share

  651. LEE TH, Chen AH
    Last-Mile Logistics of Covid Vaccination - The Role of Health Care Organizations.
    N Engl J Med. 2021 Jan 27. doi: 10.1056/NEJMp2100574.
    >> Share

  652. COHEN MS
    Monoclonal Antibodies to Disrupt Progression of Early Covid-19 Infection.
    N Engl J Med. 2021;384:289-291.
    >> Share

  653. BOTTI-LODOVICO Y, Rosenberg E, Sabeti PC
    Testing in a Pandemic - Improving Access, Coordination, and Prioritization.
    N Engl J Med. 2021;384:197-199.
    >> Share

  654. RUBIN EJ, Baden LR, Nottage K, O'Connell J, et al
    Audio Interview: An International Look at Covid-19.
    N Engl J Med. 2021;384:e19.
    >> Share

  655. PARMET WE
    Roman Catholic Diocese of Brooklyn v. Cuomo - The Supreme Court and Pandemic Controls.
    N Engl J Med. 2021;384:199-201.
    >> Share

  656. KLASS P, Ratner AJ
    Vaccinating Children against Covid-19 - The Lessons of Measles.
    N Engl J Med. 2021 Jan 20. doi: 10.1056/NEJMp2034765.
    >> Share

  657. VAN TASSEL K, Shachar C, Hoffman S
    Covid-19 Vaccine Injuries - Preventing Inequities in Compensation.
    N Engl J Med. 2021 Jan 20. doi: 10.1056/NEJMp2034438.
    >> Share

  658. RUBIN EJ, Baden LR, Abdool Karim SS, Morrissey S, et al
    Audio Interview: Covid-19 in South Africa and a New SARS-CoV-2 Variant.
    N Engl J Med. 2021;384:e14.
    >> Share

  659. KATZ LM
    (A Little) Clarity on Convalescent Plasma for Covid-19.
    N Engl J Med. 2021 Jan 13. doi: 10.1056/NEJMe2035678.
    >> Share

  660. JOYNER MJ, Carter RE, Senefeld JW, Klassen SA, et al
    Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19.
    N Engl J Med. 2021 Jan 13. doi: 10.1056/NEJMoa2031893.
    >> Share

  661. SADOFF J, Le Gars M, Shukarev G, Heerwegh D, et al
    Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine.
    N Engl J Med. 2021 Jan 13. doi: 10.1056/NEJMoa2034201.
    >> Share

  662. RUBIN EJ, Baden LR, Lee TH, Morrissey S, et al
    Audio Interview: Planning for the SARS-CoV-2 Vaccine Rollout.
    N Engl J Med. 2021;384:e13.
    >> Share

  663. LIBSTER R, Perez Marc G, Wappner D, Coviello S, et al
    Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults.
    N Engl J Med. 2021 Jan 6. doi: 10.1056/NEJMoa2033700.
    >> Share

  664. LUDVIGSSON JF, Engerstrom L, Nordenhall C, Larsson E, et al
    Open Schools, Covid-19, and Child and Teacher Morbidity in Sweden.
    N Engl J Med. 2021 Jan 6. doi: 10.1056/NEJMc2026670.
    >> Share

  665. WOOD S, Schulman K
    Beyond Politics - Promoting Covid-19 Vaccination in the United States.
    N Engl J Med. 2021 Jan 6. doi: 10.1056/NEJMms2033790.
    >> Share

    December 2020
  666. MILLER SE
    Visualization of SARS-CoV-2 in the Lung.
    N Engl J Med. 2020;383:2689.
    >> Share

  667. ACKERMANN M, Mentzer SJ, Jonigk D
    Visualization of SARS-CoV-2 in the Lung. Reply.
    N Engl J Med. 2020;383:2689-2690.
    >> Share

  668. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: A Look at Covid-19 Prevention and Care in 2020.
    N Engl J Med. 2020;383:e147.
    >> Share

  669. PERRIN JM, Kenney GM, Rosenbaum S
    Medicaid and Child Health Equity.
    N Engl J Med. 2020;383:2595-2598.
    >> Share

  670. CHATTERJEE P, Sommers BD, Joynt Maddox KE
    Essential but Undefined - Reimagining How Policymakers Identify Safety-Net Hospitals.
    N Engl J Med. 2020;383:2593-2595.
    >> Share

  671. RUBIN D, Chan-Tack K, Farley J, Sherwat A, et al
    FDA Approval of Remdesivir - A Step in the Right Direction.
    N Engl J Med. 2020;383:2598-2600.
    >> Share

  672. LEITER RE
    Reentry.
    N Engl J Med. 2020;383:e141.
    >> Share

  673. BADEN LR, Solomon CG, Greene MF, D'Agostino RB, et al
    The FDA and the Importance of Trust.
    N Engl J Med. 2020;383:e148.
    >> Share

  674. NIRULA A, Shen L, Skovronsky DM
    Neutralizing Antibody LY-CoV555 for Outpatient Covid-19. Reply.
    N Engl J Med. 2020;384.
    >> Share

  675. CASADEVALL A, Joyner MJ, Pirofski LA
    Neutralizing Antibody LY-CoV555 for Outpatient Covid-19.
    N Engl J Med. 2020;384.
    >> Share

  676. FOPPIANO PALACIOS C, Travassos MA
    Vaccinating Detained Migrants against SARS-CoV-2 - Preventing Another Tragedy.
    N Engl J Med. 2020 Dec 30. doi: 10.1056/NEJMpv2035416.
    >> Share

  677. BAROCAS JA
    Business Not as Usual - Covid-19 Vaccination in Persons with Substance Use Disorders.
    N Engl J Med. 2020 Dec 30. doi: 10.1056/NEJMpv2035709.
    >> Share

  678. BADEN LR, El Sahly HM, Essink B, Kotloff K, et al
    Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
    N Engl J Med. 2020 Dec 30. doi: 10.1056/NEJMoa2035389.
    >> Share

  679. LEE MH, Perl DP, Nair G, Li W, et al
    Microvascular Injury in the Brains of Patients with Covid-19.
    N Engl J Med. 2020 Dec 30. doi: 10.1056/NEJMc2033369.
    >> Share

  680. HAYNES BF
    A New Vaccine to Battle Covid-19.
    N Engl J Med. 2020 Dec 30. doi: 10.1056/NEJMe2035557.
    >> Share

  681. CASTELLS MC, Phillips EJ
    Maintaining Safety with SARS-CoV-2 Vaccines.
    N Engl J Med. 2020 Dec 30. doi: 10.1056/NEJMra2035343.
    >> Share

  682. HELLER HM, Gonzalez RG, Edlow BL, Ard KL, et al
    Case 40-2020: A 24-Year-Old Man with Headache and Covid-19.
    N Engl J Med. 2020;383:2572-2580.
    >> Share

  683. MAITRA A
    Holding Up.
    N Engl J Med. 2020;383:2498-2499.
    >> Share

  684. RITTENBERG E
    Sewing Masks - Resilience in the Face of Covid.
    N Engl J Med. 2020;383:2497-2498.
    >> Share

  685. TAMBYRAJA AL
    New Order, New Hope.
    N Engl J Med. 2020;383:2495-2496.
    >> Share

  686. LUMLEY SF, O'Donnell D, Stoesser NE, Matthews PC, et al
    Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers.
    N Engl J Med. 2020 Dec 23. doi: 10.1056/NEJMoa2034545.
    >> Share

  687. STONE JH, Horick NK, Healy BC
    Tocilizumab in Covid-19. Reply.
    N Engl J Med. 2020;384.
    >> Share

  688. LEAF DE, Gupta S, Wang W
    Tocilizumab in Covid-19.
    N Engl J Med. 2020;384.
    >> Share

  689. LUNDGREN JD, Grund B, Barkauskas CE, Holland TL, et al
    A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.
    N Engl J Med. 2020 Dec 22. doi: 10.1056/NEJMoa2033130.
    >> Share

  690. CHASTAIN DB, Henao-Martinez AF, Young HN
    Racial Disproportionality in Covid Clinical Trials. Reply.
    N Engl J Med. 2020;383:2488-2490.
    >> Share

  691. TOMASHEK KM, Mehta AK, Hynes NA
    Racial Disproportionality in Covid Clinical Trials.
    N Engl J Med. 2020;383:2487-2488.
    >> Share

  692. GOLDMAN JD, Osinusi A, Marty FM
    Racial Disproportionality in Covid Clinical Trials.
    N Engl J Med. 2020;383:2486-2487.
    >> Share

  693. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Covid-19 Vaccine Fundamentals.
    N Engl J Med. 2020;383:e146.
    >> Share

  694. HUNTER DJ
    Trying to "Protect the NHS" in the United Kingdom.
    N Engl J Med. 2020;383:e136.
    >> Share

  695. SALAMA C, Han J, Yau L, Reiss WG, et al
    Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia.
    N Engl J Med. 2020 Dec 17. doi: 10.1056/NEJMoa2030340.
    >> Share

  696. WEINREICH DM, Sivapalasingam S, Norton T, Ali S, et al
    REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19.
    N Engl J Med. 2020 Dec 17. doi: 10.1056/NEJMoa2035002.
    >> Share

  697. BARIC RS
    Emergence of a Highly Fit SARS-CoV-2 Variant.
    N Engl J Med. 2020 Dec 16. doi: 10.1056/NEJMcibr2032888.
    >> Share

  698. KALIL AC, Patterson TF, Mehta AK, Tomashek KM, et al
    Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.
    N Engl J Med. 2020 Dec 11. doi: 10.1056/NEJMoa2031994.
    >> Share

  699. RUBIN EJ, Baden LR, Barocas JA, Morrissey S, et al
    Audio Interview: SARS-CoV-2 Vaccination and Vulnerable Populations.
    N Engl J Med. 2020;383:e143.
    >> Share

  700. HUANG E, Jordan SC
    Tocilizumab for Covid-19 - The Ongoing Search for Effective Therapies.
    N Engl J Med. 2020;383:2387-2388.
    >> Share

  701. LEICK MB
    Telephone.
    N Engl J Med. 2020;383:2304-2305.
    >> Share

  702. POLACK FP, Thomas SJ, Kitchin N, Absalon J, et al
    Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
    N Engl J Med. 2020 Dec 10. doi: 10.1056/NEJMoa2034577.
    >> Share

  703. RUBIN EJ, Longo DL
    SARS-CoV-2 Vaccination - An Ounce (Actually, Much Less) of Prevention.
    N Engl J Med. 2020 Dec 10. doi: 10.1056/NEJMe2034717.
    >> Share

  704. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Caring for Hospitalized Patients with Covid-19.
    N Engl J Med. 2020;383:e140.
    >> Share

  705. FAJGENBAUM DC, June CH
    Cytokine Storm.
    N Engl J Med. 2020;383:2255-2273.
    >> Share

  706. LAHEY T
    The Bottom of the Health Care Rationing Iceberg.
    N Engl J Med. 2020;383:2200-2201.
    >> Share

  707. XING Y, Wong GWK, Ni W, Hu X, et al
    Rapid Response to an Outbreak in Qingdao, China.
    N Engl J Med. 2020;383:e129.
    >> Share

  708. WIDGE AT, Rouphael NG, Jackson LA, Anderson EJ, et al
    Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination.
    N Engl J Med. 2020 Dec 3. doi: 10.1056/NEJMc2032195.
    >> Share

  709. CAVALCANTI AB, Berwanger O, Zampieri FG
    Hydroxychloroquine with or without Azithromycin in Covid-19. Reply.
    N Engl J Med. 2020;383.
    >> Share

  710. CHOUDHARY R, Bohra GK, Kumar D
    Hydroxychloroquine with or without Azithromycin in Covid-19.
    N Engl J Med. 2020;383.
    >> Share

  711. KEANE MJ
    Hydroxychloroquine with or without Azithromycin in Covid-19.
    N Engl J Med. 2020;383.
    >> Share

  712. PAN H, Peto R, Henao-Restrepo AM, Preziosi MP, et al
    Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
    N Engl J Med. 2020 Dec 2. doi: 10.1056/NEJMoa2023184.
    >> Share

  713. AYDILLO T, Gonzalez-Reiche AS, Aslam S, van de Guchte A, et al
    Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer.
    N Engl J Med. 2020 Dec 1. doi: 10.1056/NEJMc2031670.
    >> Share

    November 2020
  714. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: New Studies of Covid-19 Transmission.
    N Engl J Med. 2020;383:e138.
    >> Share

  715. KATZ DH, Wilson JG, Gerszten RE
    Mining a GWAS of Severe Covid-19.
    N Engl J Med. 2020;383.
    >> Share

  716. KARIM M, Ghoussaini M, Dunham I
    Mining a GWAS of Severe Covid-19.
    N Engl J Med. 2020;383.
    >> Share

  717. KENNEDY BS, Richeson RP, Houde AJ
    Risk Factors for SARS-CoV-2 in a Statewide Correctional System.
    N Engl J Med. 2020 Nov 24. doi: 10.1056/NEJMc2029354.
    >> Share

  718. MITJA O, Corbacho-Monne M, Ubals M, Alemany A, et al
    A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19.
    N Engl J Med. 2020 Nov 24. doi: 10.1056/NEJMoa2021801.
    >> Share

  719. SIMONOVICH VA, Burgos Pratx LD, Scibona P, Beruto MV, et al
    A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia.
    N Engl J Med. 2020 Nov 24. doi: 10.1056/NEJMoa2031304.
    >> Share

  720. MANZANO GS, Woods JK, Amato AA
    Covid-19-Associated Myopathy Caused by Type I Interferonopathy.
    N Engl J Med. 2020 Nov 20. doi: 10.1056/NEJMc2031085.
    >> Share

  721. RUBIN EJ, Baden LR, Haug CJ, Morrissey S, et al
    Audio Interview: Covid-19 in Europe and New Information on Vaccines.
    N Engl J Med. 2020;383:e134.
    >> Share

  722. MALINA S, Warbelow S, Radix AE
    Two Steps Back - Rescinding Transgender Health Protections in Risky Times.
    N Engl J Med. 2020;383:e116.
    >> Share

  723. RUBIN EJ, Baden LR, Woodcock J, Morrissey S, et al
    Audio Interview: An Update from Operation Warp Speed.
    N Engl J Med. 2020;383:e127.
    >> Share

  724. CHOI B, Choudhary MC, Regan J, Sparks JA, et al
    Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host.
    N Engl J Med. 2020 Nov 11. doi: 10.1056/NEJMc2031364.
    >> Share

  725. MICHAEL NL
    SARS-CoV-2 in the U.S. Military - Lessons for Civil Society.
    N Engl J Med. 2020 Nov 11. doi: 10.1056/NEJMe2032179.
    >> Share

  726. LETIZIA AG, Ramos I, Obla A, Goforth C, et al
    SARS-CoV-2 Transmission among Marine Recruits during Quarantine.
    N Engl J Med. 2020 Nov 11. doi: 10.1056/NEJMoa2029717.
    >> Share

  727. KASPER MR, Geibe JR, Sears CL, Riegodedios AJ, et al
    An Outbreak of Covid-19 on an Aircraft Carrier.
    N Engl J Med. 2020 Nov 11. doi: 10.1056/NEJMoa2019375.
    >> Share

  728. DOLIN R, Hirsch MS
    Remdesivir - An Important First Step.
    N Engl J Med. 2020;383:1886-1887.
    >> Share

  729. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: What the U.S. Response to Covid-19 Looks Like Today.
    N Engl J Med. 2020;383:e123.
    >> Share

  730. MATIAS WR, Vaidya A, Brigl M, Bebell LM, et al
    A Patient with Fever and Dyspnea.
    N Engl J Med. 2020;383:e111.
    >> Share

  731. GUDBJARTSSON DF, Stefansson K
    Early Spread of SARS-CoV-2 in the Icelandic Population. Reply.
    N Engl J Med. 2020;383.
    >> Share

  732. COWIE BC, MacLachlan JH
    Early Spread of SARS-CoV-2 in the Icelandic Population.
    N Engl J Med. 2020;383.
    >> Share

    October 2020
  733. LEVIN M
    Multisystem Inflammatory Syndrome in Children in the United States. Reply.
    N Engl J Med. 2020;383:1795-1796.
    >> Share

  734. FELDSTEIN LR, Rose EB, Randolph AG
    Multisystem Inflammatory Syndrome in Children in the United States. Reply.
    N Engl J Med. 2020;383:1794-1795.
    >> Share

  735. ARDITI M, Bahar I
    Multisystem Inflammatory Syndrome in Children in the United States.
    N Engl J Med. 2020;383:1794.
    >> Share

  736. ALTER G, Seder R
    The Power of Antibody-Based Surveillance.
    N Engl J Med. 2020;383:1782-1784.
    >> Share

  737. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: A New Monoclonal Antibody for Covid-19.
    N Engl J Med. 2020;383:e117.
    >> Share

  738. WU K, Smith CR, Lembcke BT, Ferreira TBD, et al
    Elective Surgery during the Covid-19 Pandemic.
    N Engl J Med. 2020;383:1787-1790.
    >> Share

  739. BLENDON RJ, Benson JM
    Implications of the 2020 Election for U.S. Health Policy.
    N Engl J Med. 2020;383:e105.
    >> Share

  740. CAHAN EM, Levine LB, Chin WW
    The Human Touch - Addressing Health Care's Workforce Problem amid the Pandemic.
    N Engl J Med. 2020;383:e102.
    >> Share

  741. DEFOREST A
    The New Stability.
    N Engl J Med. 2020;383:1708-1709.
    >> Share

  742. HALABI S, Heinrich A, Omer SB
    No-Fault Compensation for Vaccine Injury - The Other Side of Equitable Access to Covid-19 Vaccines.
    N Engl J Med. 2020 Oct 28. doi: 10.1056/NEJMp2030600.
    >> Share

  743. CHEN P, Nirula A, Heller B, Gottlieb RL, et al
    SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19.
    N Engl J Med. 2020 Oct 28. doi: 10.1056/NEJMoa2029849.
    >> Share

  744. REYNOLDS HR, Adhikari S, Iturrate E
    RAAS Inhibitors and Risk of Covid-19. Reply.
    N Engl J Med. 2020;383.
    >> Share

  745. MANCIA G, Rea F, Corrao G
    RAAS Inhibitors and Risk of Covid-19. Reply.
    N Engl J Med. 2020;383.
    >> Share

  746. STRAUSS MH, Hall AS, Lavie CJ
    RAAS Inhibitors and Risk of Covid-19.
    N Engl J Med. 2020;383.
    >> Share

  747. ISLAM N, Khunti K, Chowell G
    RAAS Inhibitors and Risk of Covid-19.
    N Engl J Med. 2020;383.
    >> Share

  748. SRIRAM K, Loomba R, Insel PA
    RAAS Inhibitors and Risk of Covid-19.
    N Engl J Med. 2020;383.
    >> Share

  749. ANGELI F, Verdecchia P, Reboldi G
    RAAS Inhibitors and Risk of Covid-19.
    N Engl J Med. 2020;383.
    >> Share

  750. GANDHI M, Rutherford GW
    Facial Masking for Covid-19. Reply.
    N Engl J Med. 2020;383.
    >> Share

  751. BROSSEAU LM, Roy CJ, Osterholm MT
    Facial Masking for Covid-19.
    N Engl J Med. 2020;383.
    >> Share

  752. RASMUSSEN AL, Escandon K, Popescu SV
    Facial Masking for Covid-19.
    N Engl J Med. 2020;383.
    >> Share

  753. PLATTON S, Bowles L, Pasi KJ
    Lupus Anticoagulant in Patients with Covid-19. Reply.
    N Engl J Med. 2020;383.
    >> Share

  754. GOODING R, Myers B, Salta S
    Lupus Anticoagulant in Patients with Covid-19.
    N Engl J Med. 2020;383.
    >> Share

  755. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Tocilizumab and Covid-19.
    N Engl J Med. 2020;383:e114.
    >> Share

  756. CHOWDHURY JF, Moores LK, Connors JM
    Anticoagulation in Hospitalized Patients with Covid-19.
    N Engl J Med. 2020;383:1675-1678.
    >> Share

  757. ROSENBAUM L
    Tribal Truce - How Can We Bridge the Partisan Divide and Conquer Covid?
    N Engl J Med. 2020;383:1682-1685.
    >> Share

  758. WILENSKY GR
    Policy Lessons from Our Covid Experience.
    N Engl J Med. 2020;383:e96.
    >> Share

  759. AGARWAL SD, Sommers BD
    Insurance Coverage after Job Loss - The Importance of the ACA during the Covid-Associated Recession.
    N Engl J Med. 2020;383:1603-1606.
    >> Share

  760. BELOT A, Levy-Bruhl D
    Multisystem Inflammatory Syndrome in Children in the United States.
    N Engl J Med. 2020;383.
    >> Share

  761. STRASSLE C, Jardas E, Ochoa J, Berkman BE, et al
    Covid-19 Vaccine Trials and Incarcerated People - The Ethics of Inclusion.
    N Engl J Med. 2020 Oct 21. doi: 10.1056/NEJMp2025955.
    >> Share

  762. STONE JH, Frigault MJ, Serling-Boyd NJ, Fernandes AD, et al
    Efficacy of Tocilizumab in Patients Hospitalized with Covid-19.
    N Engl J Med. 2020 Oct 21. doi: 10.1056/NEJMoa2028836.
    >> Share

  763. RAFIEI Y, Mello MM
    The Missing Piece - SARS-CoV-2 Testing and School Reopening.
    N Engl J Med. 2020 Oct 21. doi: 10.1056/NEJMp2028209.
    >> Share

  764. KRAUSE PR, Gruber MF
    Emergency Use Authorization of Covid Vaccines - Safety and Efficacy Follow-up Considerations.
    N Engl J Med. 2020 Oct 16. doi: 10.1056/NEJMp2031373.
    >> Share

  765. WARREN RC, Forrow L, Hodge DA Sr, Truog RD, et al
    Trustworthiness before Trust - Covid-19 Vaccine Trials and the Black Community.
    N Engl J Med. 2020 Oct 16. doi: 10.1056/NEJMp2030033.
    >> Share

  766. KASER A
    Genetic Risk of Severe Covid-19.
    N Engl J Med. 2020;383:1590-1591.
    >> Share

  767. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Vaccinology and Covid-19.
    N Engl J Med. 2020;383:e109.
    >> Share

  768. GLIED S
    Health Policy in a Biden Administration.
    N Engl J Med. 2020;383:1501-1503.
    >> Share

  769. WALSH EE, Frenck RW Jr, Falsey AR, Kitchin N, et al
    Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.
    N Engl J Med. 2020 Oct 14. doi: 10.1056/NEJMoa2027906.
    >> Share

  770. SHAPIRO J, McDonald TB
    Supporting Clinicians during Covid-19 and Beyond - Learning from Past Failures and Envisioning New Strategies.
    N Engl J Med. 2020 Oct 14. doi: 10.1056/NEJMp2024834.
    >> Share

  771. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Covid-19 and the President.
    N Engl J Med. 2020;383:e104.
    >> Share


  772. Dying in a Leadership Vacuum.
    N Engl J Med. 2020;383:1479-1480.
    >> Share

  773. HORBY P, Mafham M, Linsell L, Bell JL, et al
    Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19.
    N Engl J Med. 2020 Oct 8. doi: 10.1056/NEJMoa2022926.
    >> Share

  774. CELUM C, Barnabas R, Cohen MS, Collier A, et al
    Covid-19, Ebola, and HIV - Leveraging Lessons to Maximize Impact.
    N Engl J Med. 2020 Oct 7. doi: 10.1056/NEJMp2022269.
    >> Share

  775. PAGE KR, Flores-Miller A
    Lessons We've Learned - Covid-19 and the Undocumented Latinx Community.
    N Engl J Med. 2020 Oct 7. doi: 10.1056/NEJMp2024897.
    >> Share

  776. ROSENQUIST JN
    The Stress of Bayesian Medicine - Uncomfortable Uncertainty in the Face of Covid-19.
    N Engl J Med. 2020 Oct 7. doi: 10.1056/NEJMp2018857.
    >> Share

  777. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Covid-19 Testing and the Individual Physician.
    N Engl J Med. 2020;383:e99.
    >> Share

  778. HATA SR
    The Ritual of the Table.
    N Engl J Med. 2020;383:1301-1303.
    >> Share

    September 2020
  779. RASMUSSEN SA, Lyerly AD, Jamieson DJ
    Delaying Pregnancy during a Public Health Crisis - Examining Public Health Recommendations for Covid-19 and Beyond.
    N Engl J Med. 2020 Sep 30. doi: 10.1056/NEJMp2027940.
    >> Share

  780. MINA MJ, Parker R, Larremore DB
    Rethinking Covid-19 Test Sensitivity - A Strategy for Containment.
    N Engl J Med. 2020 Sep 30. doi: 10.1056/NEJMp2025631.
    >> Share

  781. ANDERSON EJ, Rouphael NG, Widge AT, Jackson LA, et al
    Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.
    N Engl J Med. 2020 Sep 29. doi: 10.1056/NEJMoa2028436.
    >> Share

  782. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Eight Months of Action and Inaction against Covid-19.
    N Engl J Med. 2020;383:e95.
    >> Share

  783. CHRISTIE A, Neatherlin JC, Nichol ST, Beach M, et al
    Ebola Response Priorities in the Time of Covid-19.
    N Engl J Med. 2020;383:1202-1204.
    >> Share

  784. CUNEO CN, Janeway H
    From Icebox to Tinderbox - A View from the Southern Border.
    N Engl J Med. 2020;383:e81.
    >> Share

  785. YANG OO, Ibarrondo FJ
    Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19. Reply.
    N Engl J Med. 2020;383.
    >> Share

  786. KUTSUNA S, Asai Y, Matsunaga A
    Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.
    N Engl J Med. 2020;383.
    >> Share

  787. TERPOS E, Mentis A, Dimopoulos MA
    Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.
    N Engl J Med. 2020;383.
    >> Share

  788. BOLKE E, Matuschek C, Fischer JC
    Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.
    N Engl J Med. 2020;383.
    >> Share

  789. SCHWARTZ JL
    Evaluating and Deploying Covid-19 Vaccines - The Importance of Transparency, Scientific Integrity, and Public Trust.
    N Engl J Med. 2020 Sep 23. doi: 10.1056/NEJMp2026393.
    >> Share

  790. PERETZ PJ, Islam N, Matiz LA
    Community Health Workers and Covid-19 - Addressing Social Determinants of Health in Times of Crisis and Beyond.
    N Engl J Med. 2020 Sep 23. doi: 10.1056/NEJMp2022641.
    >> Share

  791. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Operation Warp Speed and Covid-19 Therapeutics.
    N Engl J Med. 2020;383:e92.
    >> Share

  792. FISHMAN JA, Roberts MB, Zhang EW, Kumar D, et al
    Case 29-2020: A 66-Year-Old Man with Fever and Shortness of Breath after Liver Transplantation.
    N Engl J Med. 2020;383:1168-1180.
    >> Share

  793. JOUNG J, Ladha A, Saito M, Kim NG, et al
    Detection of SARS-CoV-2 with SHERLOCK One-Pot Testing.
    N Engl J Med. 2020 Sep 16. doi: 10.1056/NEJMc2026172.
    >> Share

  794. EVANS ML, Lindauer M, Farrell ME
    A Pandemic within a Pandemic - Intimate Partner Violence during Covid-19.
    N Engl J Med. 2020 Sep 16. doi: 10.1056/NEJMp2024046.
    >> Share

  795. AVORN J, Kesselheim AS
    Up Is Down - Pharmaceutical Industry Caution vs. Federal Acceleration of Covid-19 Vaccine Approval.
    N Engl J Med. 2020 Sep 15. doi: 10.1056/NEJMp2029479.
    >> Share

  796. SLAOUI M, Greene SE, Woodcock J
    Bridging the Gap at Warp Speed - Delivering Options for Preventing and Treating Covid-19.
    N Engl J Med. 2020 Sep 15. doi: 10.1056/NEJMp2028535.
    >> Share

  797. EVANS MK
    Health Equity - Are We Finally on the Edge of a New Frontier?
    N Engl J Med. 2020;383:997-999.
    >> Share

  798. GOLDHAMER MEJ, Pusic MV, Co JPT, Weinstein DF, et al
    Can Covid Catalyze an Educational Transformation? Competency-Based Advancement in a Crisis.
    N Engl J Med. 2020;383:1003-1005.
    >> Share

  799. SHUREN J, Stenzel T
    Covid-19 Molecular Diagnostic Testing - Lessons Learned.
    N Engl J Med. 2020 Sep 9. doi: 10.1056/NEJMp2023830.
    >> Share

  800. GANDHI M, Rutherford GW
    Facial Masking for Covid-19 - Potential for "Variolation" as We Await a Vaccine.
    N Engl J Med. 2020 Sep 8. doi: 10.1056/NEJMp2026913.
    >> Share

  801. BLOOM BR, Nowak GJ, Orenstein W
    "When Will We Have a Vaccine?" - Understanding Questions and Answers about Covid-19 Vaccination.
    N Engl J Med. 2020 Sep 8. doi: 10.1056/NEJMp2025331.
    >> Share

  802. KEECH C, Albert G, Cho I, Robertson A, et al
    Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine.
    N Engl J Med. 2020 Sep 2. doi: 10.1056/NEJMoa2026920.
    >> Share

  803. GUDBJARTSSON DF, Norddahl GL, Melsted P, Gunnarsdottir K, et al
    Humoral Immune Response to SARS-CoV-2 in Iceland.
    N Engl J Med. 2020 Sep 1. doi: 10.1056/NEJMoa2026116.
    >> Share

    August 2020
  804. WYLLIE AL, Fournier J, Casanovas-Massana A, Campbell M, et al
    Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2.
    N Engl J Med. 2020 Aug 28. doi: 10.1056/NEJMc2016359.
    >> Share

  805. SLAOUI M, Hepburn M
    Developing Safe and Effective Covid Vaccines - Operation Warp Speed's Strategy and Approach.
    N Engl J Med. 2020 Aug 26. doi: 10.1056/NEJMp2027405.
    >> Share

  806. HORN DM, Haas JS
    Covid-19 and the Mandate to Redefine Preventive Care.
    N Engl J Med. 2020 Aug 12. doi: 10.1056/NEJMp2018749.
    >> Share

  807. STUDDERT DM, Hall MA, Mello MM
    Partitioning the Curve - Interstate Travel Restrictions During the Covid-19 Pandemic.
    N Engl J Med. 2020 Aug 5. doi: 10.1056/NEJMp2024274.
    >> Share

    July 2020
  808. CORBETT KS, Flynn B, Foulds KE, Francica JR, et al
    Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates.
    N Engl J Med. 2020 Jul 28. doi: 10.1056/NEJMoa2024671.
    >> Share

  809. CAVALCANTI AB, Zampieri FG, Rosa RG, Azevedo LCP, et al
    Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19.
    N Engl J Med. 2020 Jul 23. doi: 10.1056/NEJMoa2019014.
    >> Share

  810. BERKOWITZ SA, Cene CW, Chatterjee A
    Covid-19 and Health Equity - Time to Think Big.
    N Engl J Med. 2020 Jul 22. doi: 10.1056/NEJMp2021209.
    >> Share

  811. EGEDE LE, Walker RJ
    Structural Racism, Social Risk Factors, and Covid-19 - A Dangerous Convergence for Black Americans.
    N Engl J Med. 2020 Jul 22. doi: 10.1056/NEJMp2023616.
    >> Share

  812. BLUMENTHAL D, Fowler EJ, Abrams M, Collins SR, et al
    Covid-19 - Implications for the Health Care System.
    N Engl J Med. 2020 Jul 22. doi: 10.1056/NEJMsb2021088.
    >> Share

  813. HORBY P, Lim WS, Emberson JR, Mafham M, et al
    Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report.
    N Engl J Med. 2020 Jul 17. doi: 10.1056/NEJMoa2021436.
    >> Share

  814. NORTH CM, Dougan ML, Sacks CA
    Improving Clinical Trial Enrollment - In the Covid-19 Era and Beyond.
    N Engl J Med. 2020 Jul 15. doi: 10.1056/NEJMp2019989.
    >> Share

  815. JACKSON LA, Anderson EJ, Rouphael NG, Roberts PC, et al
    An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.
    N Engl J Med. 2020 Jul 14. doi: 10.1056/NEJMoa2022483.
    >> Share

  816. HEATON PM
    The Covid-19 Vaccine-Development Multiverse.
    N Engl J Med. 2020 Jul 14. doi: 10.1056/NEJMe2025111.
    >> Share

    June 2020
  817. MELLO MM, Silverman RD, Omer SB
    Ensuring Uptake of Vaccines against SARS-CoV-2.
    N Engl J Med. 2020 Jun 26. doi: 10.1056/NEJMp2020926.
    >> Share

  818. ELLINGHAUS D, Degenhardt F, Bujanda L, Buti M, et al
    Genomewide Association Study of Severe Covid-19 with Respiratory Failure.
    N Engl J Med. 2020 Jun 17. doi: 10.1056/NEJMoa2020283.
    >> Share

    May 2020
  819. GOLDMAN JD, Lye DCB, Hui DS, Marks KM, et al
    Remdesivir for 5 or 10 Days in Patients with Severe Covid-19.
    N Engl J Med. 2020 May 27. doi: 10.1056/NEJMoa2015301.
    >> Share

  820. BEIGEL JH, Tomashek KM, Dodd LE, Mehta AK, et al
    Remdesivir for the Treatment of Covid-19 - Preliminary Report.
    N Engl J Med. 2020 May 22. doi: 10.1056/NEJMoa2007764.
    >> Share

  821. BERLIN DA, Gulick RM, Martinez FJ
    Severe Covid-19.
    N Engl J Med. 2020 May 15. doi: 10.1056/NEJMcp2009575.
    >> Share

    April 2020
  822. GANDHI RT, Lynch JB, Del Rio C
    Mild or Moderate Covid-19.
    N Engl J Med. 2020 Apr 24. doi: 10.1056/NEJMcp2009249.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016